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Trichosanthin is a basic protein extracted and 
purified from the root tuber of Trichosanthes kirilowii 
Maxim of cucurbi taceae. It is a single chain 2 S, 600 
dalton polypeptide of 234 amino acid residues. The in 
vitro cytotoxic activity of trichosanthin on 8 human 
cell lines, including 2 normal fibroblast cell lines was 
assessed by a cellular protein content assay. The 
sensitivity of different cell lines to trichosanthin 
varied considerably. The choriocarcinoma cell line (Jar 
and BeWo) , and the cervical carcinoma cell line (CC3) 
were highly sensitive towards trichosanthin with ICSO 
values ranging from 3.3-7.8 }1g/ml'. However the HeLa 
cervical carcinoma line, the Baron tongue squamous 
carcinoma line, the aCCl ovarian clear cell carcinoma 
line and two normal f ibroblast cell lines were less 
sensitive to trichosanthin. In a co-culture system of 
coexisting tumour cell line Jar, CC3 or aCCl with normal 
fibroblast line Fibl, the fibroblast cells were 
significantly resistant to trichosanthin while the order 
of sensitivity of the three tumour cell lines towards 
trichosanthin was the same as in the single cell line 
tests. In vitro effects of trichosanthin were further 
vii 
potentiated by the action of adriamycin or cisplatin 
resulting in an inhibition of growth of Jar and HeLa 
cell lines. Trichosanthin showed activity against 
choriocarcinoma cells in vivo with a significant 
decrease of tumour size and prolongation of life-span of 
tumour bearing mice. 
As tr ichosanthin is a natural protein display ing 
anti-tumour activity in vitro and in vivo, a series of 
studies were undertaken on the morphological, cellular 
and molecular events elicited in the trichosanthin-
sensitive choriocarcinoma Jar cell line as a prototype 
for the study of the mechanism of anti-tumour action of 
this agent. The effects of trichosanthin on the rates 
of DNA, RNA and protein synthesis were assessed by 
measuring cellular incorporation of tritiated thymidine, 
uridine and methionine from culture fluids. The results 
show that trichosanthin disrupts DNA and protein 
synthesis with less effects on synthesis of RNA, 
suggesting that it inhibits macromolecule synthesis in a 
manner similar to protein synthesis inhibitors. 
Morphological studies of trichosanthin-treated Jar cells 
by light microscopy and electron microscopy revealed 
that trichosanthin invariably caused apoptosis of Jar 
cell death. The binding of 125r-trichosanthin to both 
viii 
Jar and HeLa cells was 'unsaturable and unreversible. 
The introduction of unlabelled trichosanthin did not 
lead to the dissociation of bound 125 1 trichosanthin in 
Jar cells. Specific binding of trichosanthin on the 
surface of Jar or HeLa cell is therefore not an 
essential step for cytotoxicity. 
In conclusion trichosanthin, displaying selective 
in vitro and in vivo activities against human tumour 
cell lines, is a potential anti-tumour agent. Its anti-
tumour action may be due to the inhibition of cellular 
protein synthesis leading to the suppression of cell 
growth, cell apoptosis and ultimately cell death. 
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Chapter 1 Introduction 
The first part of Chapter 1 is a literature review 
on trichosanthin research relevant to the direction and 
scope of this thesis. In particular, available 
information on the discovery, chemistry and pharmacology 
of tr ichosanthin is presented and discussed in detail. 
The chapter continues with an outline of the specific 
objectives of the project, ending with a brief account 




Tumour chemotherapy was pioneered in 1946 by Gilman 
and Philips following the pharmacologic evaluation of 
the mustard compounds which were previously used as 
chemical warfare agents (Gilman & Philips, 1946). By 
the 1950's the rate of introduction of useful new agents 
began to accelerate: folic acid antagonists, purine 
analogues and adrenocorticosteroids appeared in rapid 
succession (Cline & Haskell, 1980). By the 1960 ' s a 
whole new class of anti-tumour agents became available 
(Bergenstal et al., 1960; Evans et al., 1961; DiMarco et 
al., 1963; Johnson et al., 1963; Broome, 1968). 
Since 1946, at least 36 new drugs have been 
introduced for the treatment of different malignancies, 
of which a group of antibiotics (bleomycin, 
adriamycin) (Blum et al., 1973; Tan et al., 1973; DiMarco 
et al., 1963), alkylating compounds and related agents 
(cyclophosphamide, procarbacin, cisplatin)(Stolinsky et 
al., 1970; Rozencweig et al., 1977), antimetabolites 
(cytosine arabinoside, 6-mercaptopurine, methotrexate) 
(Evans et al., 1961; Burchenal et al., 1953; Bleyer & 
Dedrick, 1977), natural products (etoposide, 
vincristine) (Rozencweig & Von Hoff, 1977; Owellen et 
J 
al., 1977) and hormones (corticosteroids, estrogens, 
tamoxifen) (Pearson et al., 1949; Morgan et al., 1976) 
are considered as "essential" drugs by the World Health 
Organization (Hansen et al., 1985). 
Most conventional chemotherapeutic agents act by a 
general, nonselective interference in cellular processes 
and cell growth (Cline & Haskell, 1980). Indeed many of 
such cytotoxic agents are almost equally detrimental to 
normal and neoplastic tissues (Remers, 1984). They are 
potentially toxic to the patient's normal tissues having 
a high rate of cellular proliferation such as the normal 
bone marrow elements (Dimitrov & Nodine, 1974; Metcalf & 
Moore, 1976; DeVita et al., 1982), the gastrointestinal 
epithelial cells (Goldin & Carter, 1982), and the cells 
of the hair follicles and skin (Cline & Haskell, 1980). 
Clinically useful anti-tumour agents are desired with a 
greater toxicity for malignant cells than for normal 
cells of the tumour-bearing host (Cline & Haskell, 
1980) . 
Traditional Chinese medicine has for centuries 
followed an empirical approach (Lien & Li, 1985), with 
little animal experimentation prior to clinical 
application. As a result thousands of herbs, plants, 
and preparations have been handed down to contemporary 
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practitioners in China and many other parts of the 
world. Only in the last few decades have the 
composition and efficacy of various Chinese herbs and 
plants been subjected to modern methods of analysis 
(Lien & Li, 1985). 
Natural products, especially compounds isolated 
from higher plants and microorganisms, have served as 
rich sources of novel drugs including many anti-tumour 
drugs. In China, some of the thousands of species of 
plants used either in traditional or Chinese herbal 
medicine have been screened for possible anti-tumour 
effects. Many compounds with cytotoxic and/or anti-
tumour activity have been discovered (Hsu, 1982; Hsu et 
al., 1979; Chen et al., 1980; Chu, 1982). Although a 
few of them have been used clinically or selected for 
further development, many compounds never went beyond 
experimental stages of drug development (Hsu, 1982). 
Trichosanthin, a purified plant protein is 
extracted from Chinese herb, T ian Hua Fen, the root 
tuber of Trichosanthes kirilowii Maxim (Cucurbitaceae) 
(Wang et al., 1979; Wang et al., 1986). It is of 
particular interest to us in the search for an effective 
natural anti-tumour agent as its chemical structure has 
been elucidated and it has been used clinically to 
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terminate mid-trimester pregnancy with only mild side 
effects(Anon., 1971a, 1973a; Jin, 1985, 1988). 
Furthermore, tr ichosanthin has been shown to have 
significant effects against trophoblast cells in the 
study of its mechanism of action as an abortifacient 
(Anon., 1976a; Xiong et al., 1976). Trichosanthin also 
exhibits a potent immunosuppressive effect for both cell 
mediated and humoral immune responses (Leung et al. 
1986), and has been used to treat some trophoblastic 
diseases in mainland China without appropriate pre-
clinical tests and controlled trial (Anon., 1972a, 
1975a, 1976b, 1978a; Jin, 1985; Yao, 1978; Huang, 1987). 
The objective in this project is to focus on the 
activity of trichosanthin against human tumours and its 
mechanism of action. 
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1.2 History of Trichosanthin 
Trichosanthin is extracted and purified from Tian 
Hua Fen, the root tuber of a Chinese medicinal plant-
Trichosanthes kirilowii Maxim (Cucurbitaceae) which 
grows widely in southern China (Li, 1590; Wang et al., 
1979; Wang et al., 1986). 
As early as in the later Han Dynasty, the famous 
physician Zhang Zhong-Jing (about A.D. 150-219) had 
mentioned Tian Hua Fen as traditional herbal medicine in 
his classical book: Jin Kuei Yao Lui(Summaries on 
Household Drugs). Later in the Tang Dynasty, the 
distinguished physician Sun Si-Miao(A.D.590-682) 
recorded the first successful application of Tian Hua 
Fen to deal with the disturbance of menstruation in his 
famous medical book "Supplement to Prescriptions Worth 
a Thousand Gold". In "The Peaceful Holy Benevolent 
Prescriptions" compiled by Wang Huai-Yin in the Song 
Dynasty (A.D.1010). T ian Hua Fen was recommended for 
inducing abortion in the recipe "Gui Xin Scattered 
Prescriptions". 
In the late Ming Dynasty the great naturalist and 
physician Li Shi-Zhen (A. D .1518-1593) had in his book 
"Ben Cao Gang Mu"(Compendium of Materia Medica) (1590), 
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a very comprehensive and scientific compilation of the 
indications, described pharmacological properties of 
Tian Hua Fen as an effective drug for "resetting 
menstruation" and "treating the retention of the after-
birth" . 
For a long time Tian Hua Fen with a mixture of 
other ingredients was used externally as aborticide in 
folk-medicine (Wang et al., 1976a). In the past two or 
three decades, as part of the fertility control measures 
in China, Chinese practitioners and clinical doctors in 
cooperation with pharmacologists, biologists and 
chemists have screened the original 7 or 8 ingredients 
of the Tian Hua Fen prescriptions for inducing abortion 
down to two and finally to one pr inc ipal ingredient, 
Tian Hua Fen (Wang et al., 1976a). Further studies on 
the isolation and purification of the active 
abortifacient factor led to the crystallization of the 
active protein trichosanthin (Jin et al., 1981; Wang et 
al., 1986). 
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1.3 Preparation of Trichosanthin 
Externally the root tubers of Trichosanthes under 
name of T ian Hua Fen are pale brown-white in colour, 
usually marked with irregular longitudinal stripes, and 
internally they are white and amylaceous (Stuart, 1911; 
Wang et al., 1979) (Figure 1.3.1). 
The root tubers are collected fresh, cut and 
pressed to obtain their juice. This is then fractionally 
precipitated with acetone and purified by 
crystallization from barbiturate buffer (Jin et al., 
1981). The yield of crystallized product was about 0.05% 
(on a fresh root basis). The pure crystal is 
homogeneous on agarose plate and sodium dodecyl 
sulphate (SDS) polyacrylamide electrophoresis, and ge1-
permeation. The active protein is named trichosanthin 
(Jin et al., 1981; Wang et al., 1986). 
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Figure 1.3.1 Trichosanthin is derived from the root of a 
plant in the cucurmber family, Trichosanthes kiri10wii 
Hllxim. (a) l'richosdnthes k .irilowii, (b) root of 
Trichosanthes kirilowii. 
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1.4 Chemistry of Trichosanthin 
Trichosanthin is a basic protein of PI (Isoelectric 
Point) 9.4. Its molecular weight as determined by SDS-
polyacrylamide gel electrophoresis is 24,000 dal tons. 
In its molecule there are one histidine residue, one 
tryptophan residue and 4 methionine residues, but no 
cysteine and cystine (Jin et al., 1981; Gu et al., 
1984; Wang 1985). 
1.4.1 Primary structure 
Trichosanthin molecule does not contain cysteine or 
cystine and has free amino- and carboxyl-terminal so 
that it is a polypeptide chain protein. The main amino 
acid sequence of the principal primary structure of 
trichosanthin has been proposed as shown in Figure 
1.4.1. The trichosanthin molecule is composed of 234 
amino acid residues forming an open polypeptide chain. 
The calculated molecular weight is 25,610 daltons (Wang, 
1985; Wang et al., 1986). 
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Figure 1.4.1 Primary s~ructure of trichosanthin 
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1.4.2 Three dimensional structure 
X-ray crystallographic analysis reveals that the 
crystals of trichosanthin from barbiturate buffer belong 
to monocyclic system (Pan et al. 1985a). Trichosanthin 
has both an alpha and a beta structure. There are 8 
alpha -helices (4 longer and 4 shorter) and 13 strands 
of beta-structure, forming 4 beta-pleated sheets. In 
addition there are 8 beta-turns in the polypeptide 
chain. The 8 alpha-helices are located towards centre 
of the molecule surrounded by the 4 beta-pleated sheets. 
Recently the positions of side chains in 
trichosanthin molecule have been determined from the 
molecular model constructed according to the electron 
density map of 3 and 2.6 A resolutions (Pan et al., 
1985a,b) . 
The study on the laser Raman spectrum of powdered 
trichosanthin crystals reveals the presence of 
absorption bands for phenylalanine, tryptophan, tyrosine 
and two amide groups (amides I and I I I) ( Zhu et al., 
1985). The amide I and amide III bands are 
characteristic of beta-pleated sheets and random 
structures. But the absorption band related to the 
random structure is very weak. 
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Trichosanthin was partially digested with 
chymotrypsin to produce peptide fragments (Ke et al., 
1988) . Two large fragments, I and 11, have been 
isolated and identif ied as C-terminal peptides located 
at sequence positions between 79-234 and 107-234. Their 
relative molecular weight determined by electrophoretic 
mobility on SDS gel were 16,000 and 14,000 daltons 
respectively. studies using fluorescence quenching 
measurements by titrating anti-trichosanthin antibody 
fractions with trichosanthin and fragment I and 11 
showed that four epitopes were present in intact 
trichosanthin and one each epitope in fragment I and 11. 
Since part of the amino acid sequence of fragment I and 
fragment I lover lapped, and no apparent epi tope was 
found between sequence positions 79-106, the epi topes 
is therefore located between sequence position 107 and 
234 (Ke et al., 1988). 
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1.5 Pharmacology of Trichosanthin 
1.5.1 Pharmacologic Action 
Abortifacient action 
Trichosanthin has shown to be effective in inducing 
mid-term abortion in laboratory animals (Anon., 1978b; 
Chang et al., 1979) and humans (Anon., 1976a, 1976c; 
Jin, 1985). Trichosanthin is also effective in 
terminating early pregnancy in mice (Liu et al., 1981; 
Tarn et al., 1985) and humans (Liu et al., 1985). 
Trichosanthin given to pregnant rabbits on Day 14 
of gestation by intramuscular injection (4 mg) or by 
intravaginal administration (32 mg) induced abortion 
(Anon., 1978b). Trichosanthin given once only induced 
mid-term abort ion in the mice and rabbits. The 
effective intraperitoneal dose on the induction of 
abortion in 10- or 11-day pregnant mouse was 50 ~g. In 
the rabbit a dose and state of pregnancy-dependent 
response to trichosanthin-induced abortion was 
encountered. A dose as low as 0.5 mg trichosanthin in 
22-day pregnant rabbit was adequate but 2.0 mg was 
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needed in 17-day pregnant rabbit. When compared with 
prostaglandin F2 alpha, an established abortifacient, 
trichosanthin appeared to be more effective and 
associated with less side effects in the induction of 
abortion in rabbit (Chang et al., 1979). An 
intramuscular injection of 5-10 mg of crude extract of 
the root of Trichosanthes could induce mid-trimester 
abortion with a success rate of 99% (Anon., 1976a). The 
termination of mid-term . gestation of 3-6 months was 
induced by intraamniotic administration of trichosanthin 
(0.48 mg x gestation month), successful termination 
occurred in 99% of cases(Jin, 1985). 
Trichosanthin given to pregnant mice as two 
successive doses (250 ~g/animal) on Day 4-5, resulted in 
complete inhibition of pregnancy (Dai, 1983). 
Trichosanthin given intraperitoneally to mice on Day 1-6 
of gestation led to the termination of early pregnancy 
(Tarn et al., 1985). The intrauterine administration of 
1.2-2mg of trichosanthin in combination with 
intramuscular injections of 100 mg of testosterone 
propionate and 0.5-0.8 mg of reserpine was used in 
terminating human early pregnancy with a successful 
abortion rate of 93.8%(Liu, 1985). 
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Anti-tumour activity 
Intraperitoneal injection of trichosanthin at dose 
of 0.2 mg/mouse twice resulted in significant growth 
inhibition of mouse hepatoma compared to untreated 
controls (p < 0.01) (Guo et al., 1980). The anti-growth 
effect of trichosanthin was observed in treated mice 
following subcutaneous transplantation of sarcoma 180 
cells (solid type). Trichosanthin given to tumour 
bearing mice at a dose of 2.5 mg/kg daily for 7 days, 
resulted in 45% inhibition of tumour growth in mice (Pan 
et al., 1985c). Leung et al. (1986) showed 
trichosanthin could inhibit the growth of a murine 
malignant tumour(MBL-2) both in vitro and in vivo. 
Trichosanthin was also active in suppressing the growth 
of Ehrlich ascites carcinoma in vivo in mice at 5 mg/kg 
resulting in a significantly increased lifespan of the 
mice (Guo et al., 1989). 
Immunomodulatory activity 
Trichosanthin is a potent immunosuppressive protein 
(Leung et al., 1986)that could affect humoral immunity 
and a variety of cell-mediated processes. At non-
cytotoxic concentrations it markedly inhibited the 
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mitogen-induced lymphoproliferative response, the 
generation of a primary alloreactive cytotoxic T 
lymphocyte response in vitro, the production of 
interleukin-2 by concanavalin A activated splenocytes 
and the effector functions of macrophages in vitro. 
Inhibition of human immunodeficiency 
replication 
virus 
Recently McGraph et al. (1989) reported that 
formulated preparation of trichosanthin-Compound Q 
(GLQ223) produced dose-dependent inhibition of human 
immunodeficiency virus (HIV) replication in acutely 
infected cultures of T-lymphoblastoid cells (VB cell 
line) . Treatment with Compound Q selectively reduced 
levels of detectable viral proteins compared to total 
cellular protein synthesis and produced a selective 
decrease in levels of viral RNA in relative to total 
cellular RNA in acutely infected cells. Selective anti-
HIV activity was also observed in cultures of primary 
monocyte/macrophages chronically infected with HIV in 
vitro. The anti-HIV activity of Compound Q in both 
acutely and chronically infected cells and its activity 
in cells of both lymphoid and mononuclear phagocytic 
lineage make it an interesting candidate as a potential 
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therapeutic agent in HIV infection and acquired immune 
deficiency syndrome (AIDS). 
1.5.2 Pharmacokinetics 
Informations on the pharmacokinetics of 
trichosanthin were mainly derived from four different 
studies: 
(1) Distribution and excretion of 131I-labelled 
crude extract of Tian Hua Fen in pregnant women 
(Cao et al., 1976) . 
(2) Distribution of trichosanthin antigen or 1251_ 
labelled trichosanthin in pregnant mice at 
various times by means of indirect fluorescence 
immunoassay or whole body autoradiography 
technique (Hsu et al., 1976; Gao & Zhou, 1978). 
(3) Determination of trichosanthin distribution in 
the pregnant women by radioimmunoassay 
(Tso et al., 1978a,b). 
(4) Intravenous infusion of 131I-labelled crude 
extract of Tian Hua Fen in cases of malignant 
hydatidiform mole (Anon., 1976c; Dai, 1983). 
One hour after intramuscular injection, 
trichosanthin concentrations were highest in the renal 
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cortex as well as in feces in the intestine, followed by 
the placenta, liver, spleen, and lungs in descending 
order. The myometrium, fetal liver and red blood cells 
also contained trichosanthin, however, there was no 
trichosanthin detected in the amniotic fluid. 
Detectable blood levels of trichosanthin after 
intramuscular injection appeared within 10 min. The 
serum level of trichosanthin reached the peak level 4 h 
after the intramuscular . injection. The instantaneous 
maximal quantity in peripheral circulation was 
approximately 5% of the intramuscular dose, followed by 
a gradual decrease to 50% of the peak value after 8 h 
and 15% by 24 h. Trichosanthin was not detectable in 
any other tissues except the renal cortex 16 h after 
intramuscular injection. The amount of trichosanthin 
retained in the local sites after 4 h was about 60% of 
the administered dose, and after 24 h around 30% only. 
Trichosanthin was not metabolized by the body. 
Following intravenous administration the half-life 
of trichosanthin was about 1 h. High drug concentration 
first appeared in the liver, then in the kidneys and 
bile. The amount excreted in the ur ine reached 
approximately 67% within 24 h. 
This information suggests that given 
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intramuscularly trichosanthin is readily absorbed, 
whereas, trichosanthin administrated intravenously 
concentrates in the liver and is subsequent~y excreted 
through the kidney and bile. The clearance of 
trichosanthin from the body is rapid. 
After intraamniotic injection, trichosanthin was 
not detected in the maternal serum, and its urinary 
excretion was very low. Most of trichosanthin remained 
in the amniotic cavity, but flowed out together with the 
amniotic fluid during abortion. A certain amount of 
tr ichosanthin was also detected in the serum of the 
fetus. 
Trichosanthin given intraamniotically can cross the 
amnio-placenta barrier slowly, but very little enters 
the maternal circulation. Therefore, the systemic side 
effects caused by the intraamniotic injection are 




Generally, the toxic side effects of trichosanthin 
were lessened with the increase in the purity of the 
preparation (Tian, 1988). 
Allergic reaction 
Trichosanthin injected in pre-sensitized mice could 
cause allergic reactions even leading to death of the 
mice (Anon., 1976d). This reaction has been utilized to 
create pathological models for the evaluation of 
antiallergic drugs(Anon., 1978c; Zhang, 1979). These 
allergic reactions were attributed to trichosanthin as a 
foreign protein. 
Systemic toxicity 
Preclinical toxicological studies of trichosanthin 
performed in dogs by intramuscular administration of 
crude preparations in a range concentrations (0.2-4.0 
mg/kg) disclosed acute gastrointestinal toxicities 
manifesting as anorexia and even food refusal in the 
0.4-2.0 mg/kg group (Anon., 1976d). These animals 
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gradually recovered within 2-5 days. In addition, it was 
found to cause transient ST segment depression in the 
electrocardiogram (ECG) which was also recovered within 
2-3 days. There was no marked change in nonprotein 
nitrogen(NPN) level. The serum glutamic pyruvic 
transaminase (SGPT) was slightly elevated in few dogs. 
Generalized dilation and stasis of capillaries and 
venules as well as mild degeneration of hepatic and 
renal parenchymal cells were seen. Meanwhile, in the 3-
4 mg/kg group, most dogs died after 1-2 weeks due to 
serious prostration. The ST segment of the ECG appeared 
to decline gradually. The T wave was markedly inverted. 
Multiple premature beats also appeared in a few dogs. 
There was a rapid increase of NPN which reached about 
200 % of normal controls, accompanied by decreased 
sodium and chloride concentrations in blood, suggesting 
metabolic acidosis would perhaps be responsible for 
these symptoms. Elevation of the SGPT in this group was 
more marked than that in the low-dose group. The 
pathological changes included petechiae in multiple 
organs (including the adrenal cortex), necrosis of the 
proximal renal tubules, and sometimes focal necrosis of 
the hepatic parenchyma. After injection of 
trichosanthin in both groups, the white blood cell count 
increased to as high as 30,000-40,000/mm3 , and the 
neutrophil count also reached 90% with subsequent 
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recovery within one week(Anon., 1976d). 
Electroencephalogram (EEG) studies revealed that 
trichosanthin had a depressive effect on the central 
nervous system. Abnormal slow waves similar to those 
elicited by pentobarbital sodium were observed after 
intramuscular or intravenous injection of trichosanthin 
in rabbits or monkeys(Anon., 1978c). 
Local stimulation of the quadriceps muscle of 
rabbits caused various extents of local congestion and 
petechiasis but no necrosis (Anon., 1976d). 
Subacute LDSO in mice 
The subacute LDSO were revealed 10 days after 
intravenous injection of 2.26 mg/animal freeze-dried 
juice of Tian Hua Fen; 0.6 mg/animal a crude preparation 
of trichosanthin; 0.29 mg/animal dialysed trichosanthin 
and 0.236 mg/animal crystalline trichosanthin (Anon., 
1976a; Zhu, 1974; Xiong, 1988). 
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1.6 Clinical Use of Trichosanthin 
1.6.1 Clinical application 
Clinical trials have demonstrated that 
trichosanthin is effective in treating the followings. 
Termination of early pregnancy 
In 222 cases at 5-14 week gestation given 
intramuscularly crystalline trichosanthin 1.2 mg, 
abortion success rate was 94.2%. The duration of 
induction was 2.1 ± 0.6 days (Wang et al., 1989). In 
another series of 402 women at 6-10 week gestation, 
crystalline trichosanthin (1-1.2mg) administered by the 
extra- or intraamniot ic, or intracerv ical route, 
complete abortion occurred in 96.4% of cases. The time 
taken to abortion was from 3-10 days with a mean of 6 
days (Wu & Liu, 1988). During abortion there were no 
changes in urine routine test, red and white blood cell 
counting, serum SGPT, urea and creatinine levels, and 
ECG examination (Wu & Liu, 1988). 
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Mid-trimester ~bortion 
There are many reports on the use of trichosanthin 
administered intraamniotically or intramuscularly to 
terminate mid-trimester pregnancies (Anon., 1971a, 
1973a, 1975c, 1976b, 1976c, 1976e, 1976f; Jin, 1985; Wu 
& Liu, 1988). The dose range was 5-10 mg of the refined 
preparations or 1.2-2.4 mg of the crystalline 
preparation. Results from 40 hospitals in Shanghai 
showed a 97.3 % success rate in 12,764 cases 
administered by trichosanthin to terminate mid-trimester 
pregnancy (Anon., 197 6c) . The abortion interval was 
about 4.5 days. Jin (1985) reported the termination of 
mid-trimester (3-6 month gestation) pregnancy in 100 
women induced by intraamniotic administration of 
trichosanthin with 99% success rate. There was an 
elevation of the body temperature to 38-39 °c for the 
first 2-3 days in 60.4% of the cases. The high fever 
was usually accompanied by headache, joint pain and 
leukocytosis (an average increases of 3,599/mm3 ) which 
returned to normal when the temperature fell. During 
abortion there were no abnormalities in red blood cell 
counting, haemoglobin level,. and functions of heart, 
liver and kidneys. Little uterine bleeding (usually 
less than 100 ml) occurred during and after abortion 
(Jin, 1985). 
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Missed abortion and intrauterine death 
seventy three cases of missed abortions at 3-5 
months gestation were given crystalline trichosanthin 
(1.2 mg) intramuscularly. Complete abortion occurred in 
95. 7% of cases. In half of the missed abortions the 
termination was completed in less than 4 days with an 
average interval of 4.1 ± 1.8 days. In 86% of cases the 
blood loss was less than 50 ml. There was an elevation 
of temperature to 38-39 0 C for the first 2-3 days in 
50.0% of the cases (Jin, 1985). Twenty nine cases of 
intrauterine death were treated by trichosanthin (1.2 
mg), complete expulsion was found in 97% of cases (Jin, 
1988) . 
Ectopic pregnancy 
seventy one cases of unruptured ectopic pregnancy 
were treated by intramuscular injection of crystalline 
trichosanthin (1.2 mg). The success rate of this 
conservative treatment was 85.9% (Lu & Jin, 1988). If 
the pregnancy test remained positive 1-2 weeks after the 
first injection, another injection preceded by a skin 
test for hypersensitivity of trichosanthin was 
effective in 78.2% cases (Anon., 1974a, 1975b, 1976g, 
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1979a) . 
Hydatidiform mole and choriocarcinoma 
Intramuscular injection of trichosanthin (1.2-2.4 
mg) caused degenerative necrosis of the molar tissue. 
The mole was completely or partially expelled in 3-6 
days. A blood loss of 50-300 ml occurred in 75% cases. 
However, in 25% patients with no molar expulsion in more 
than 10 days, curettage was performed to remove the 
degenerated and organized molar tissues (Zhu, 1974; 
Anon., 1976h, 1978a; Jin, 1985). Clinical report from 
hospital in mainland China showed high cure rates (90-
98%) in malignant mole treated by trichosanthin alone or 
in combination with conventional chemotherapeutic drugs, 
other herbal medicines or surgery (Anon., 1974b; Yao, 
1978) . Side effects of trichosanthin were reported to 
be mild and tolerable when compared to chemotherapeutic 
drugs. In the treatment of 10 cases with 
choriocarcinoma, trichosanthin (5-10 mg) given 
intramuscularly or intravenously for 5 doses with 5-7 
day interval caused urine hCG decrease (less than 100 
U/L), pelvic sign negative and disappearance of 
metastatic foci in lungs in 9 cases (Jin, 1988). Others 
reported the overall cure rate of choriocarcinoma 
treated with trichosanthin was about 50% (Anon., 1972a, 
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1975a; Anon., 1976f). 
AIDS 
As trichosanthin preparation - Compound Q (GLD223) 
appears to kill HIV-infected macrophages in vitro 
without damaging uninfected cells and to block 
replication · of the virus in T-helper cell (McGraph et 
al., 1989), it has been used to treat AIDS. 
Anecdotal reports from the San Francisco 
participants in a Compound Q treatment program 
unofficially organized by Project Inform (Wright et al., 
1989) indicated that 12 of 19 patients experienced a 
return of , or increase in, energy. Nine gained weight 
(average of 4 pounds) over the course of the program, 
and 7 felt that they could think more clearly after 
Compound Q treatment. However, at least 6 of 52 people 
in the program developed severe central nervous system 
dysfunction after taking small dose of the drug. Three 
of 6 people died during the program or shortly after it 
ended, but it is unclear whether their deaths resulted 
from taking Compound Q. Therefore it is too early to 
draw any meaningful conclusion about use of Compound Q 
to treat AIDS at present. Compound Q works on cells 
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infected with HIV, but it has not been proven to affect 
free-floating virus in the blood. For this reason some 
investigators believe that this agent is not a cure for 
HIV infection, but eventually it may become an adjuvant 
treatment regimen for AIDS. 
Others 
Administration of trichosanthin led to symptomatic 
relief in respiratory infections such as acute 
bronchitis and pneumonia (Anon., 1973a). The herb can 
be used together with Manis pentadactyla, a thorn of 
Gleditsia sinensis, and the flower of Lonicera japonica, 
as in "Xianfang Huoming Yin" (Life-saving immortal 
decoction) for the treatment of mastitis. It can also 
be mixed with water to treat skin eczema(Anon., 1973a; 
Ren, 1955). 
1.6.2 Mechanism of action 
Until now only the mechanism of abortifacient 
action of trichosanthin was investigated in detail. It 
seems that tr ichosanthin induces fetal death and 
abortion by severely damaging syncytiotrophoblasts of 
11) 
- l1 1: l a - 11 - al villi (l\non ., 1976a ; Wa ny - t a l ., 19 '/ Gb , 
178 ). Th la mag of the s yn c ytiotropho blast s o f t h -
placental villi produced clumps of disintegrating cell s 
released into the circulation, which hinders placental 
blood circulation and leads to tissue necrosis and 
eventually abortion (Wang et al., 1986). Further 
studies sho\.Jed that the abortifacient activity of 
trichosanthin might also result from the inhibitory 
effects on the biosynthetic activity of the implanting 
embryos and the endometrial cells (Chan et al., 1985; 
Tarn et al., 1985). The mechanism of immunosuppression 
caused by trichosanthin has not been resolved. 
Immunosuppression appears not to be attributed to direct 
lymphocytotoxic effect of trichosanthin since exposure 
of mouse splenocytes to a high concentration (100 ~g/ml) 
of the protein for at least 48 h did not lead to any 
significant reduction of cell viability. Although 
protein synthesis inhibition could account for the 
immunomodulatory effect of trichosanthin, it has not 
been formally established that this is the only or the 
major mechanism involved in immunosuppression (Leung et 
al., 1986). 
The mechanism of trichosanthin action against 
tumour cells has not yet been elucidated, and it needs 
further investigation. In cell-free rabbit reticulocyte 
\ I 
s y t - Ill tl- i hosa n t il in in h ibits rot i n Ry n h s i 8 
(Xi ng e t al ., 1980 ; Ye u ng et al ., 19 8 8 ). l\ d irect 
interact ion of t h e pro t e in wi th t h e tumour cell s vJ as 
probab l y involved (Leung et al., 1986). To st u dy th e 
mec h a ni sm o f anti-tumo ur action of trichos anth i n i s the 
major object ive of this project, it will be elabora ted 
i n Chapter 3 . 
1.6.3 Adverse reactions 
Side effects 
Intramuscular injection of trichosanthin in the 
buttocks could produce painful local irritation and the 
enlargement of ingu inal lymph nodes. other toxic 
reactions include fever, headache, urticaria, skin 
rashes, sore throat, stif f neck, elevated white blood 
cell count and eosinophilia. Some of these were 
probably hypersensitivity reactions (see below). 
Usually, these systemic and local reactions disappeared 
spontaneously within a few days to one week after 
administration (Anon., 1974a, 1975d, 1976c, 1976e; Jin, 
1985; Zhu, 1974). These reactions were milder followin g 
i n t r aam n iotic a d minist r atio n than after i nt ramus c ula r 
i n jection. 
\ / 
'1' 11 adv t" ffects ca n be reliev d by giv n l o ng -
a - i ng o cti ote pi n s or adrenocorti co l hormo nes 8u c h 8 
dexamethasone (Jin, 1985; Jin & Zhou, 19 90 ) . 
Symptomatic treatment with an antipyretic, analgesic 
and antihistaminics have also been advocated (Anon. , 
1975c, 1975d, 1978d). 
other adverse reactions occurred occasionally 
included angioneurotic oedema, cardiac arrhythmias, 
hypotension, hepatosplenomegaly, SGPT elevation, 
albuminuria, and profuse uterine bleeding following 
aborti o n (Anon., 1976f; Jin, 1985). Specific attention 
should be paid to any bleeding tendency. According to 
clinical data the incidence of profuse bleeding 
following abortion induced by trichosanthin was 1.7% 
(Wang et al., 1979). Hypofibrinogenemia and fibrin 
precipitation in the placenta were seen in the case of 
abortion (Yuang et al., 1978). Abnormal bleeding was 
probably due to the loss of fibrinogen which was caused 
by intravascular blood coagulation and secondary 
fibrinolysis. Severe hemorrhage could be prevented by 
monitoring the fibrinogen and. platelets levels, bleeding 
time and clotting time and timely treatment (Anon., 
1976e, 1976i, 1976j, 1978c, 1978d). 
F 1 1 \.., - II P 0 f 1 1 tl tl w me n vI h h ad tri' l1 sa n h i n 
n u ab r t i o n of mid-trimest e r preg n a ncies [ o r 1- 6 
y e ars r evea l ed t h a t the effec t of t r i c ho sa n t h i n o n the 
\..,0111 a n' s me n s t r u a t ion, g e n era 1 he a 1 t h and fer t i l it y vI a s 
not signif ica nt (Zhuang et al., 1977). 
Ana phylacti c reactions 
Trichosanthin has strong antigenicity. Allergic 
reactions may occur as typical anaphylactic shock (0.02% 
of cases) (Anon., 1974a, 1976k; Lin, 1979), typical serum 
sickness type reactions (urticaria, fever, intense 
pruritus and respiratory embarrassment occurring 3-7 
days after exposure) and a variety of skin rashes, fever 
and eosinophilia. Skin test with trichosanthin could 
identify many hypersensitive individuals in such cases. 
1.6.4 contraindications 
Trichosanthin should not be given to patients with 
positive skin tests or active heart and renal disease. 
It should be used with caution in patients with severe 
a n aemia, mental diso r ders and active infectio ns , a n d 
· II P 11 Y P to - 11 s it i V i - y r a ~ t i o n vI i. t h it n 1 t~ -. v i ( I 1 n 
u s (An o n., 1976e , 1 9 7 6f ; Wa n g et a l., 1 9 7 9 ). 
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1.7 Obj e ctives of Project and Or g a n ization of The s i s 
The objec t i ve s of the project were t o unde r take an 
i n d ept h study of the anti-tumour effect s of 
tric ho santh i n and its mechanism of action. 
The detailed aims of the investigation were: 
I. To assess the effects of trichosanthin against 
the growth of human tumour cells in vitro. 
I I . To observe the inhibitory effects of 
trichosanthin on co-cultured cells in vitro. 
Ill. To probe the effects of the combination of 
trichosanthin with conventional anti-tumour 
drugs: adriamycin and cisplatin on cultured 
human tumour cells. 
IV. To investigate the inhibitory effects of 
trichosanthin on choriocarcinoma bearing nude 
mice. 
V. To compare the effects of purified trichosanthin 
with Tian Hua Fen polysaccharide on 
choriocarc i noma cells in vitro. 
VI . T ) °h a III t- [ h 1 
r i -h sa n t h i n o n c horiocarci noma c ll s . 
VI I . To prov ide informat ion o n t he binding of 
radio labelled trichosanthin with huma n tumo u r 
ce lls. 
VI I I. To analyse the effect of trichosanthin o n 
macromolecule synthesis of choriocarcinoma 
cells. 
The remainder of this thesis is divided into three 
Chapters and two Appendices. In the Chapter 2 the 
spectrum of anti-tumour activity of trichosanthin in 
vitro is presented. The inhibitory effects of 
trichosanthin on the growth of tumour cells in vitro 
when used in combination with other conventional anti-
tumour d r ugs, and the therapeutic efficacy of 
trichosanthin on human choriocarcinoma cell line bearing 
nude mice in vivo are also described. Chapter 3 presents 
the study on anti-tumour mechanism of trichosanthin. 
Chapter 4 is devoted to a general discussion of the 
results presented in the preceding chapters. 
The details of procedure for the establishment of 
an ovarian carcinoma cell line and the statistic al 
method used in data analyses make up Appendix 1 and 2 . 
Chapter 2 Anti-tumour Activity of Tricho sant h in 
I n Vitro and I n Vi v o 
This chapter is devoted to the activities o f 
trichosanthin against human tumour cells in vitro and in 
vivo. The first section (Section 2.1) descr ibes the 
cytotoxic effect of trichosanthin on cultured tumour 
cells using cellular protein content assay. The second 
section (Section 2.2) presents the response of co-
cultured tumour cells with normal fibroblast cells to 
trichosanthin. The third section (Section 2.3) describes 
the role of tr ichosanthin in combination therapy with 
conventional anti-tumour drugs on tumour cells. The 
fourth section (Section 2.4) describes the sensitivity 
of human choriocarcinoma xenografts in nude mice to 
trichosanthin. The final section (Section 2.5) presents 
the comparison of anti-tumour activity of two 
preparations of trichosanthin and its polysaccharide 
component. 
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2.1 Cytotoxic Effects of Tricho sa n t h i n o n 
Cultured Tumour Cells 
2.1.1 Introduction 
Trichosanthin is a potent cytotoxic agent against 
placental trophoblasts (Xiong et al., 1976) and hence it 
has been used to induce mid-trimester abortion and to 
terminate early pregnancy (Jin, 1985; Liu et al., 1985; 
Wu & Liu, 1988; Wang & Zhong, 1989). The ability of 
tr ichosanthin to inhibi t the growth of animal tumour 
cells (Guo et al., 1980; Leung et al., 1986; Guo et al., 
1989) has led to its consideration as an anti-tumour 
agent. The present study aims to assess the effects of 
trichosanthin on the growth of human tumour cell lines 
in vitro. 
The use of cell cultures to screen the cytotoxicity 
of anti-tumour drugs, has been widely accepted as an 
economic and rapid in vitro approach to an otherwise 
costly and time consuming effort (Borenfreund and 
Puerner, 1987). 
\ ' 1 
1\ 9 t ll 11 numb r , d t e r mi l1 d by m c n B o f a 
h In yt Olll t l" , c orre l ates c l osel y wit h t h e ce ll prot e in 
n t n t ( N a k a g a \.J a e t a 1 ., 198 5 ), a ce 1 1 u 1 a r pro t e i n 
assay was used in this study instead of c ont e n t s of 
vi ab l e ce lls or colonies counting to determine the 
effect s of trichosanthin against human cell growth in 
v it r o . Th i s pro tein content assay can be semi-automated 
using a c o mputer programmed spectrophotometer and 
reduces observer error. Therefore it provides a simple 
and highly efficient method of testing chemosensitivity. 
Using this assay six human tumour cell lines and 
t wo normal human fibroblast cell lines were tested for 
the effects of trichosanthin on their growth. Also, the 
in vitro survival curves of choriocarcinoma (Jar) and 
cervical carcinoma (HeLa) cell lines after trichosanthin 
treatment \.; ere analysed by applying this cellular 
protein assay as well as the established methods of 
trypan blue exclusion and [3 H)thymidine incorporation. 
In addition to the direct effect on cell growth, 
the effect of trichosanthin on the secretion of human 
chorionic gonadotrophin (hCG) in choriocarcinoma cells 
(Jar) in vitro was also evaluated. 
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2.1.2. Materials and methods 
Experimental agents 
Crystalline trichosanthin dissolved in sterile 
saline at 1.2 mg/ml was purchased from the Jinshan 
Pharmaceutical Co., Shanghai, China. Trichosanthin 
solutions were made up with culture medium immediately 
before use and sterilized by filtration (0.45 ~m filter, 
Millipore Corp., MA, USA). [methyl-3H]thymidine (2.0 
Ci/mmol) was obtained from Amersham International PLC., 
UK. 
Cells and culture conditions 
Eight human cell lines were acquired from several 
sources. Human char iocarc inoma cell lines (Jar and 
BeWo) were obtained from Or R.A. Pattillo, Medical 
College of Wisconsin, USA. Human cervical carcinoma 
(HeLa) and human tongue squamous cell carcinoma (Baron) 
cell lines were provided by Drs P.F. Ki and Paul Cheng, 
Department of Medicine, The Chinese University of Hong 
Kong, respectively. Human cervical carcinoma cell line 
w a offered b y Or E.C. Ch e w, Departm n t o f 
1\nat my, T h e Chinese University of Hong Ko n g , \,AJh i l e 
human o varian clear cell carcinoma cell line (OCC1) was 
nel,..;ly establ ished in this department. The biological 
characteristics of OCC1 line are described in Appendix 
1. Human normal skin fibroblast cell lines (Fib1 and 
Fib2) were provided by Mr P.K. Lam, Department of 
Surgery, The Chinese University of Hong Kong. 
Individual cell lines grown as monolayers were 
initially expanded (two passages) with culture medium in 
either RPMI 1640 Medium (GIBCO, NY, USA) (Jar, BeWo, 
CC3, OCC1, Fib1 and Fib2 cells) or Dulbecco's Modified 
Eagle Medium (GIBCO, NY, USA) (HeLa and Baron cells) 
supplemented with 10% (v/v) fetal bovine serum, 100 
IU/ml penicillin and 100 I1g/ml streptomycin (Flow 
Laboratories, UK). The cells were incubated at 37°C in 
an atmosphere of 5% CO2 . Established adherent cell 
monolayers approaching 80% confluency were harvested 
with 0.05% trypsin and 0.02% EDTA (Flow Laboratories, 
UK) . Cells from different passages were frozen down in 
culture medium with 10% fetal bovine serum and 10% 
dimethyl sulphoxide and stored in liquid nitrogen for 
generation of seed stock. Following recovery of seed 
stock, cell lines were subjected to test of population 
d u bli n g tim a nd c y totox icit y a ssay. 
Te s t o f cell doubling time 
The doubling times of 8 cell lines were determined 
by cell counting. Logarithmically growing cells were 
seeded into a 24-well sterile culture plate (Corning, 
NY, 4 USA) at 2 x 10 cells per well (15.5 mm diameter). 
Cells in three wells were harvested on Day 1, 2, 3, 4, 
5, 6 and 7 after seeding. The cells were washed twice 
with phosphate buffered saline (pH 7.2), and 0.2 ml of 
0.05 % trypsin and 0.02 % EDTA was added to each well. 
After cells detached, 0.8 ml of culture medium 
supplemented with 10% fetal bovine serum was added to 
stop the trypsin action. Cell were then pipetted 
rapidly to break up the cell clumps. The cell 
suspension was delivered by Pasteur pipette to fill the 
counting chamber on both sides of a Neubauer 
hemocytometer. The number of cells in each well was 
calculated. The cell growth curve was constructed from 
cell counts performed at one day interval. The doubling 
time, i.e., the time taken for the culture to increase 
two-fold in the middle of the exponential, or "log" 
phase of growth was derived from this curve (Freshney, 
1987). 
J otox icit y a ssays 
The effects of trichosanthin on the growth of J a r 
c ells and HeLa cells were tested using three tes t 
methods: 
1) Cell protein content assay. 
2) Trypan blue exclusion assay. 
3) [3 H] thymidine incorporation assay. 
Cell viability was assessed by the cell protein 
content assay and it ylaS validated by comparing with the 
established trypan blue exclusion test and the 
radiolabelled thymidine incorporation assay in 2 cell 
lines (Jar and HeLa), the other cell lines were then 
tested with this assay. 
1) Cell protein content assay 
The methodology described below represents a 
III i f i .ati n of t h or i gi na l cell u la r pro t i n aooriY 
d sc ri b d b y Holde n e t al. (1973). I n pri ncipl e , t he 
I 
vi a ble c ell number/well is directly proportional to cell 
pro tein c o ntent, which following solubilization, can be 
measured s pectrophotometrically. Logarithmically 
growing cells were plated out in triplicate in 24-well 
sterile culture plates (Corning, NY, USA) at 4 x 104 
cells per well (15.5 mm diameter) containing 0.5 ml of 
culture medium. After 24 h incubation, the medium was 
then replaced by culture medium containing trichosanthin 
at concentrations of 0.2-100 ~g/ml. After the cells had 
exposed to trichosanthin for either 24 or 48 h at 37°C 
in a 5% CO2 atmosphere, the medium was aspirated and 
discarded (in Jar cell culture the medium was removed 
and kept at -20°C pending later hCG assays). The wells 
were washed twice with 1 ml aliquots of phosphate 
buffered saline (pH 7.4). In the initial experiment for 
each cell line, the floating cells from decanted culture 
medium amd cell-washed phosphate buffered saline (pH 
7.4) were collected and subjected to a dye exclusion 
assay and reseeding to test their viability (see below). 
The cells remained attached to culture wells 
representing surviving viable cells were dissolved in 
0.5 ml 1M NaOH for 1 h at room temperature. Finally the 
total cellular protein was determined using a 
modification of the Lowry's method (Lowry et al., 1951). 
T h foll \v i ng procedu res was u sed . T h e 0 . 2 ml of abo v 
NaOH ce ll-ly s ate solution was transfer red to a 10 x 70 
mm pol y p ro pylene tube (Sarstedt, USA) containing 2 ml of 
* Lowr y's solution C . For each set of assays, prote i n 
standards were prepared consisting of 0.2 ml of various 
concentrations (3.13 200 J.1g/ml) of bovine serum 
albumin in 1 M NaOH plus 2 ml of Lowry' s solution C. 
After mixing the tube was allowed to stand for 10 min at 
room temperature. All tubes received 0.2 ml of Folin-
Ciacalteu's phenol reagent (Merck, Darmstadt). Thirty 
minutes after phenol addition, the mixtures were read in 
a semi-automated computer-programmed spectrophotometer 
(Response, Gilford Instrument, Ohio, USA) at 750 nm. 
Protein content per tested well was derived from a 
standard curve. The cytotoxic activity of trichosanthin 
was analysed as the percentage of surviving cells to 
the untreated control (presented as the protein 
content in test/control x 100%). Graphs were 
therefore prepared manually with response curves. 
The inhibitory concentraion, values for 
* 
Lowry's solution: solution A, 20 g Na 2 C03 , 4 g NaOH 
pellets water to 1 litre (store in plastic bottle) ; 
solution B, equal parts of 1% curic sulfate and 2 % 
sodium potasium tartrate (unstable; prepare only as 
required); solution C, 98 ml solution A and 2 ml 
solution. 
a 11 11 li ne w re d termi ne d fro m th e graphs aB the 
tr i h sa n t hin c oncentr a tio n cau s ing a 50')' i nh ibition of 
t he ce ll population. The IC 50 was the n u sed t o compare 
the re lative sensitivity of each cell 
trichosanthin. 
2) Trypan blue exclusion assay 
li n e to 
Logarithmically growing cells were seeded in 
triplicate to a 24-well sterile culture plate (Corning, 
NY, USA) at 4 x 10 4 cells per 15.5 mm diameter well in 
0.5 ml culture medium in the same manner as was used for 
cell protein content assay, and incubated for 24 h at 
37°C in 5% CO2 atmosphere. Trichosanthin was then added 
to each cell culture. The range of the final 
trichosanthin concentration was 0.2-100 pg/ml. After 48 
h incubation the wells were washed twice with phosphate 
buffered saline (pH 7.4). Then 0.2 ml of 0.05% trypsin 
and 0.02% EDTA solution was added to each well. When 
cells detached, 0.4 ml of culture medium with 10% fetal 
bovine serum was added to stop the trypsin action. 
Cells were then pipetted rapidly to break up the cell 
lumps, and 0.2 ml of 0.4% trypan blue added to 0.6 ml 
of tumour cell suspension. The mixture was delivered by 
I , / 
~f . llar-y 1= ip tt to fi ll he counting c hamber n o Lh 
sides of a Neubauer hemocytometer. The numbers o f 
stai ned ce lls and total cell number were counted . The 
total uIlstained cells, which represent viable cells, was 
then calculated. The cell survival rate is the 
percentage of the unstained viable cell number in 
trichosanthin treated cultures to that in untreated 
cultures. 
3) [3HJthymidine incorporation test 
A total of 200 ~l of culture medium containing 1 x 
104 logarithmically growing cells per well were plated 
into 96-well sterile microplate (Corning, NY, USA). 
Cells were allowed to attach to the plates for 24 h at 
atmosphere. Trichosanthin solutions 
in a range of concentrations (0.2-100 ~g/ml) were then 
added and the cells exposed for further 48 h. One hour 
before the end of the trichosanthin exposure, 1.0 ~Ci of 
[methyl-3HJthymidine in 10 ~l culture medium was added 
to each well. At the end of the incubation period the 
cells were washed twice with phosphate buffered saline 
(pH 7.4), once with ice-cold methanol, and extracted 
three times with ice-cold 10% trichloroacetic acid. 
Fi nally , t h c 11s wece digested i n 1 M NaOH and t h e 
radi acti v it y '.vas count e d u s ing 3 ml of sci ntillation 
solutio n c ontaining 4.5 g of 1,4-bi s [2 - ( S-
p henyloxazolyl)] benzene (POPOP), 150 mg of 2,5-
d iphe nyloxazole (PPO), 500 ml of Triton X-lOO per lit r e 
o f t o luene in a liquid scintillation counter (Liquid 
Scintillation Counter LS 3801, Beckman, USA). Results 
we r e expressed as a percentage of the control 
[3 H ] thymidine incorporation for each concentration of 
trichosanthin tested. Each concentration was tested in 
triplicate and the mean result obtained. 
Effect of trichosanthin on hCG secretion in Jar 
cells 
The concentrations of hCG in the media collected 
from the cultures of Jar cells treated with or without 
trichosanthin were determined by a radioimmunoassay kits 
(Diagnostic Products Corporation, CA, USA). The least 
detectable concentration of - hCG is 3 mIU [1st IRP 
75/537] for this kits. Media with treated or untreated 
cells were centrifuged at 1500 g, 15 min at 4°C. Control 
medium, which had not been inoculated with cells, had no 
tab l 1 v 1 f hCG. Th hCG co nce n tration in h e 
m i 111ll \ .J a s III a s 11 red at 2 4 h a nd 4 8 h. 
S t a ti sti c al analysis 
All values are expressed as the mean ± SEM. Results 
were obtained for 3 experiments in each assay. Inter-
assay coefficient of variation was calculated to express 
the precision of three kinds of cytotoxicity assay. 
Pearson's correlation coefficient was used to express 
the association between trichosanthin IC SO value and 
cell doubling time. 
2.1.3. Results 
The doubling times of cell lines under the 
conditions in this study were as follows: Jar cells, 39 
h; BeWo cells, 43 h; HeLa cells, 42 h; CC3 cells, 44 h; 
Baron cells, 46; OCC1 cells, 38 h; Fib1 cells, 21 h; and 
Fib2 cells, 24 h. 
In the initial cytotoxicity experiment for each 
11 li n t h floati ng cel l s , wh ic h wer c ollect u fr o m 
de a n ted c u lt u re med ium a nd ce l l-washed pho s pha t 
b u ffered sa line were stained with trypan b lue . Positive 
staining was shown in 98.0 ± 1.8% of tested cell s . When 
re seede d onto well with culture medium, these floa ting 
c ells could not reattach to the well bottom or 
p r o li fer at e further. These findings suggest that mo s t 
floating cells are dying or dead cells. In contrast, 
97.1 ± 2.1 % of cells which were still attached to well 
excluted trypan blue, suggesting these are viable cells. 
Cultured cell inhibition as a function of 
trichosanthin concentration was determined using the 
cell protein content assay in all eight cell lines. The 
responses of the cultured human cells towards 
trichosanthin are shown in Figures 2.1.1-2.1.2. The 
cells were incubated with trichosanthin for 24 h or 48 h 
and cell survival estimated by determining the amount of 
protein left in each culture well, which represents the 
remaining viable cells still attached to the culture 
well. At each trichosanthin concentration the cell 
survival decreased as the . exposure time increased. 
Choriocarcinoma cells (Jar and BeWo) appeared to be the 
most sensitive to trichosanthin among these cell lines. 
The respe ctive IC 50 values were 3.3 and 3.5 ~g/ml after 
h xp 8 U [" • Th C '3 ce ll s were ale se n sitive o 
tri ho sa n t h i n wi th a n I CSO of 7.8 11 9 /m 1 . Howe ver H La , 
Baron, OCC 1 , Fib1 and Fib2 cells were not as sensitive 
to t ri c hosanthin as Jar and SeWo cells. Furthermore , 
t here wa s no signif icant relationship between the 
re sponse of cells to trichosanthin (after 24 o r 48 h 
exposure) and their doubling time in vitro (r = -0.49 or 
-0.47, p > O.OS, respectively) (Table 2.1.1). 
Comparisons of in vitro assay systems in response 
to trichosanthin were performed for trichosanthin-
sensitive Jar cells and trichosanthin-insensitive HeLa 
cells. The results obtained with the three methods 
agreed with each other, as shown in Figure 2. 1. 3 and 
2 .1.4. The shape of the survival curves was similar for 
both Jar and HeLa cell lines in each of the three 
assays. The inter-assay coefficients of variation were 
9.2-10.4%, 14.2-1S.4% and 13.6-1S.6% for protein content 
assay, trypan blue assay and thymidine incorporation 
assay, respectively. 
The hCG levels in media from Jar cells were 
normalized and presented per mg cell protein at the time 
of harvest. As shown in Figure 2.1.S, the hCG secretion 
[ Jar 11 8 aft r t r e a t me n t wit h tr i c h o s an t h i n '-'Ja 8 
d creased in a dose- and time-depende n t ma nner . Th e 
I C50 , the concentration of trichosanthin which c aused 
50 ~ inhibition of hCG secretion in Jar cells, was 1 .4 5 
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Figure 2.1.1. Cytotoxicity of trichosanthin on Jar (a), 
BeWo (b), HeLa (c), and CC)· (d) cells. The perc entage 
of 8 U r v i v a 1 vJ as t h a t 0 b s er v e din c ell p ro t e i n co n ten t 
a s 8 a y f 011 0 \<) i n g a 2 11 (0) 0 r 48 (.) hex p o 8 U re t o 
Lr i c hos an t h i n a s deser i lJ e d in Hater ials and He t hod s. 
T h e ex per i men t al points r epresents the mean from 3 
replic a t e we ll s . The S EH is re presented b y ve rt i c a l 
bars vlh e n t h i 8 ex ceeds t he 8 i ze of t he symbo l s . 
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Figure 2.1.2 Cytotoxicity of trichosanthin on OCCl 
(a), Baron (b), Fibl (c) and Fib2 (d) cells. The 
percentage of survival \.Jas that observed in cell 
p rotein content assay following a 24 (0) or 48 (.) 
h exposure to trichosanthin as described in Haterials 
and l1ethods. The experimental points represent t he 
mean fr o m 3 repli c ate wells. The SEH is repl-esented by 
ve rt i c al bars when this exceeds the size of the 
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Figure 2.1.3 Comparison of survivAl curves for JAr cell 
line in cell protein content Assay (0) I trypan blue 
1 . 3 tl . 1" t . exc \161.0n assay (.) or ( H) . lym1.( 1.lle 1.llcorpora -1.011 
ass a y (1\) 8 f t ere x po S lll- e tot r i ch 0 san t h i Jl for 4 8 h. 
Each point represents the mean of three \vells. The 
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Fjgure 2.1.4 Comparison of survival curves for lIeLa 
cell line in cell protein content assay (0), trypan 
blue exclusion assay ( • ) or (3 11 ] thymidine 
incorporation assay (A.) after exposure to 
tr1.chosanthin for 48 h. Ea c h p oi nt r ep l:esents the 
me a n o f tht-e e "Je l l s. Th e SEH bars h a ve b ee n omi.tted 
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Figure 2.1.5 Inhibi tion of heG secretion by 
trichosanthin in Jar human choriocarcinoma cells. 24 h 
exposure (0); 48 h exposure (.). Each point is the 
mean ± the su of 3 culture wells. 
f 
JOO 
Table 2 .1.1 Ce ll line charac t e ri s tic a nd c omparative i n 
v ' tro se n s itivities to trichosanthin (TCS) 
-- - ------------------------------------------------- - ------------
Ce ll line : o r igi n Ce ll dou b ling 
time (h) 
a 
IC 50 value ( ~g / ml) 
afte r exposure t o TCS 
24 h 48 h 
-~ . ----- - ------------------------------------------------- - -- - - ---
Ja r :choriocarcinoma 39 10.1 3.3 
BeWo:choriocarcinoma 43 10.3 3.5 
CC3:cervical carcinoma 44 18.2 7.8 
HeLa:cervical carcinoma 42 30.5 15.4 
OCC1:ovarian clear cell 38 44.5 24.2 
carcinoma 
Baron:squamous cell 46 29.5 16.6 
carcinoma of tongue 
Fib1: normal fibroblast 21 38.1 19.9 
Fib2: normal fibroblast 24 40.1 22.2 
a 
The inhibitory concentration of trichosanthin leading to 50% 
inhibition of the cell population. 
2.1. 4 . Di s cussion 
Xiong et al. (1976) reported that trichosanth in 
exerted direct and specific injurious effects on huma n 
syncytiotrophoblasts, while no injurious effects could 
be observed on human amniotic or hepatoma cells, even 
when the tr ichosanthin concentration was increased ten 
folds. In another subsequent study (Xiong and Lu, 
1981), the injurious effect of trichosanthin on other 
types of cultured cells was examined. The authors 
reported that trophoblast cells of hydatidiform mole 
were the most sensitive to trichosanthin when compared 
to cells from the fetal renal cortex, HeLa cells, 
decidual cells, nasopharyngeal carcinoma cells and 
hepatoma cells. In both studies the criteria of 
sensitivity was based only on morphological features. 
Recently Tsao et al. (1986) observed selective cytotoxic 
effects of trichosanthin on human choriocarcinoma cells 
in vitro. Similar to their finding the cytotoxic 
effects of trichosanthin on cultured cells observed in 
this study were also not prominent after 24 h exposure, 
while continued incubation with trichosanthin for 48 h 
enhanced the cytotoxic activity. 
The dala obtai n d i n t h is st udy indi c a t s t h a 
tl" i c hosa n t h i n e xe rts signi f icantly cy t ot o x icit y against 
some huma n t umo ur c ell lines , espe cially c hor i oc a rci noma 
Jar and Se Wo cells and cervical carcinoma CC3 ce l ls. On 
the other hand, normal fibroblasts are insensitive t o 
trichosa nthin. I n v iew of the anecdotal reports in 
early cl i nical trials of treating choriocarcinoma and 
malignant hydatidiform mole, and the fact that it is 
with extremely low toxicity towards normal tissues in 
vivo (Jin, 1985; Yao, 1987), it might prove to be of 
benefit in the treatment of human malignancies. 
The data summarized in Table 2.1.1 also illustrate 
that the cytotoxic effects of trichosanthin seem to be 
independent of the cell proliferation rate, as judged by 
population doubling times. This suggests that this 
selective sensitivity probably related to certain 
inherent properties of the tumour cell. These 
properties will be further elaborated in Chapter 4. 
The effects of trichosanthin on the secretion of 
hCG in Jar cells was also investigated using hCG 
radioimmunoassay. An attempt to correlate the extent of 
th e i nhibition of hCG sec r etion with cytotoxicity of 
(, I 
l r ' -h u ll h i n s h wed t h at muc h h igh r 1 v 1 0 f 
tri h sant h i n were requi red to i nh ibit cell gro wth th a n 
were needed to inhibit the s e cretion o f hCG , s uggesting 
t ha t tr i c hosanthin can significantly inhibit ei t he r t he 
sy n t he s is o r secretion of hCG in intact Jar cells. 
Since the 1950s, many investigators have tried to 
devel o p in vi t ro or in vivo methods to predict the 
response of individual tumours to anti-tumour drugs (Von 
Hoff and Weisenthal, 1980; Weisenthal, 1981). Such 
chemosensitivity assays could play an important role on 
selecting the most efficient drugs with which to treat a 
given tumour. 
A widely used method in vitro of chemotherapy 
sensitivity testing is the clonogenic assay developed by 
Salmon and coworkers (Hamburger et al., 1977; Salmon et 
al. , 1 978 ) . However, this assay has practical 
difficulties, such as a long incubation time and low 
plating efficiencies of some tumour cells resulting in 
adequate colony forming in only 40 % of cell suspension 
(Weisenthal and Lippman, 1985; Carney & Winker, 1985). 
The most promis i ng short-term test is the dye 
( ) ) 
X I II i n a s say de ve l ope d b y Weise n t hal et a l . ( 1983 ). 
Viabl ells ha ve the abil i ty t o e xc l ud e d ye s uc h a s 
tr ypa n blue , nigros in and erythrocin B. A number of 
au t h o rs have shown that the end-point of the dye 
exclusion assay is comparable to that of the clonogenic 
assay (Carmichael et al., 1987; Laurent et al., 1986; 
Bird et al., 1987). However, this method is labour-
intensive and subject to observer error (Pieters, 1989). 
Another commonly used short-term test is the 
cellular macromolecular precursor incorporation assay 
using isotope labelling such as [3HJthymidine (for DNA 
synthesis), [3 H]uridine (for RNA synthesis), [3 H]leucin 
or [3 H]methionine (for protein synthesis) This method 
also has the disadvantage to deal with radioactive 
materials and include steps which are relatively time-
consuming (Twentyman & Luscombe, 1987). 
In the present study a cell protein content assay 
was used to determine the in vitro inhibitory effects of 
tr ichosanthin on var ious human cells. The results of 
comparing the cell protein content assay with the other 
two in vitro chemosensitivity tests showed that this 
assay correlated well with dye exclusion and thymidine 
incorporation assays in generating response curves for 
tri h osa n t h i n fro m bot h Jar and HeLa cell lines. 
HO\..Je ver , t h is c e ll pro t ein conte nt a ss ay is mu ch more 
ef f ic i e nt a nd rapid and not subject to observe r e rror. 
The simplicity of this assay permits the testing of 
multiple r eplicates and concentrations of several drug s 
on many tumo ur cell lines. It may also be used to test 
tumour cell lines with low cloning efficiencies. This 
sensitive, quantitative, semi-automated assay thus is 
suitable for the evaluation of the cytotoxic effects of 
new chemotherapeutic agents. However this assay is not 
applicable to test cell lines growing in suspension. 
2.2 Eff e cts of Trichosanthin on Co-cul ture d 
Cell Lines In Vi tro 
2.2.1 Introduction 
In studies of the abortifacient action of 
tr i chos anthin, it has been found that this plant protein 
can induce severe damage to the trophoblast cells of 
placental villi (Wang et al., 1976b; Wang et al., 1978; 
Xiong et al., 1976). As described in Section 2.1 
trichosanthin is also active against the growth of 
various human tumour cells in vitro. The IC 50 values 
of trichosanthin for choriocarcinoma Jar cell line, 
cervical carcinoma CC3 line, ovarian carcinoma aCC1 line 
and normal fibroblast Fib1 line are 3.3, 7.8, 24.2 and 
19.9 ~g/ml after 48 h exposure respectively. 
suggests its potential as an anti-tumour agent. 
This 
The clinically useful anti-tumour agents must have 
a greater toxicity for malignant cells than for normal 
cells of tumour-bearing host (Cline & Haskell, 1980). 
In order to further assess the inhibitory effects of 
t richo s an t hin on the growth of tumour cells, a mixed 
L L . u l \ I t ' y m i n w 11 i . h t h nor m a 1 [ i } rob 1 i1 B 8 'vJ r , 
- u l t Ul" d i n mo nola yers wi t h t umo u r cel l s v/as us d j n 
t h is study. 
2.2.2 Materials and methods 
Agent and cell culture 
The sources of crystalline trichosanthin and tested 
cell lines, and cell culture conditions were the same as 
that previously described in Section 2.1. 
Cytotoxic assay 
Three tumour cell lines were individually co-
cultured with Fib1 cells and treated simultaneously 
with trichosanthin. They were first seeded at equal cell 
densities of 4 x 10 5 cell/25 cm2 flask (eorning, NY, 
USA) at the beginning of each co-culture experiment. 
Twenty four hours after seeding, trichosanthin was added 
t o the mixed culture. The final trichosanthin 
concentration was 4 or 8 ~g/ml. The cells were cultured 
fo r 4 8 h, then passaged and cultured in trichosanthin-
ult u t" III d i U Ill [ ra n t 11 r 48 h. Th [ 
- ri h sa n h i n w re observed at 4 8 h intervals . 
2.2.3. Results 
The effects of trichosanthin on three co-cultured 
systems of three human tumour cell lines (Jar, CC3 and 
aCC1) with normal human skin f ibroblasts are shown in 
Figures 2.2.1-2.2.3. 
In co-culture of Jar and Fib1 cells as shown in 
Figure 2.2.1, most of Jar cells appeared to have 
cytoplasmic vacuoles and nuclear condensation after 
treatment with trichosanthin at either 4 J.1g/ml or 8 
J.1g/ml. This was,especially significant in those treated 
with 8 J.1g/ml trichosanthin. After 48 h subculture, the 
Jar cells disappeared in the co-culture treated by 4 
J.1g/ml or 8 J.1g/ml trichosanthin, but in both co-cultures 
Fib1 cells remained healthy. 
In co-culture of CC3 and Fib1 cells as shown in 
Figure 2.2.2, after treatment with trichosanthin 4 J.1g/ml 
( t" 4 h, III st CC3 ells did not s h .... , s ign i ( i a n t 
III rphol gical c h a nges . J\ fter s u bc u lt u re , a few CC3 c e ll s 
remai ned wi t h g r owing Fibl cells. Ho we ver , u sing 8 
J..1g/ ml for 48 h some CC3 cells showe d ev ide nce of 
degener atio n and after subculture only growing Fibl 
cells were seen. 
In co-culture of OCCl and Fibl cells as shown in 
Figure 2.2.3, significant morphological changes were not 
seen in OCCl cells after treatment either with 4 J..1g/ml 
or 8 J..1g/ml trichosanthin when compared with controls. 
After subculture, both OCCl and Fibl cells continued to 
grow. 
( b ) 
Figure 2.2.1 Effects of trichosanthin on 48 h co-
cultures of human choriocarcinoma cells (Jar) and 
human fibroblasts (Fib1) (x400). (a) control culture 
of Jar and 'Fib in trichosanthin-free medium. (b) 
s ubcultured cells from culture in (a). 
( d ) 
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Figure 2.2. 1 Effects of trichosanthin on 48 h co-
cultures of human choriocarcinoma cells (Jar) and 
human fibroblasts (Fib!) (x400). (c) mixed culture 
of Jar and Fibl in 4 J.1g/ml trichosanthin. (d) 
subcultured cells from culture in (c). The only cell 
type was fibroblasts. 
( ,f) 
( f ) 
Figure 2.2.! Effects of trichosanthin on 48 h co-
culture of human choriocarcinoma cells (Jar) and human 
fibroblasts (Fib!) (x400). (e) mixed culture of Jar 
and Fib in 8 pg/ml trichosanthin. (f) subcultured 
cells from culture 
disappeared. 
in (e). The choriocarcinoma cells 
/ ( ) 
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Figure 2.2.2 Effects of trichosanthin 011 
cultures of human cervical carcinoma cells 
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co-
and 
human fibroblasts (Fibl) (x400). (a) control culture 
of CC) and Fibl in trichosanthin-free medium. (b) 
subcultured cells from culture in (a). 
/ J 
.... "'. 
( d ) 
Figure 2.2.2 Effects of trichosanthin on 46 h co-
cultures of human cervical carcinoma cells (CC3) and 
human fibroblasts (Fib!) (x400). (c) mixed culture of 
CC) and Fib in 4 J.19/ml trichosanthin for 48 h. (d) 
subcultured cells from culture in (c). Only a few 
degenerated cervical carcinoma cells were seen. 
n 
( f) 
Figure 2.2.2 Effects of trichosanthin on 48 h co-
cultures of human cervical carcinoma cells (CC3) and 
human fibroblasts (Fib!) (x400). (e) mixed culture of 
CC3 and Fibl in 8 ~g/ml trichosanthin. (f) 8ubcultured 
cells from culture in (e). CC3 cells disappeared 
completely. 
I $ 
( b ) 
Figure 2.2.3 Effects of trichosanthin on 48 h co-
cultures of human ovarian carcinoma cells (OCCI) 
(x400) . (a) control culture of OCCl and Fibl in 
trichosanthin-free medium. (b) subcultured cells from 
culture in (a). 
( d ) 
Figure 2.2.3 Effects of trichosanthin on 48 h co-
cultures of human ovarian carcinoma cells (OCCI) 
(x400). (c) mixed culture of OCCl and Fibl in 4 P9/ml 
trichosanthin. (d) subcultured cells from culture in 
( c) • 
/ 'J 
( f ) 
Figure 2.2.3 Effects of trichosanthin on 48 h co-
cultures of human ovarian carcinoma cells (OCCl) and 
human fibroblasts (Fibl) (x400). (e) mixed culture of 
OCCl and Fib in 8 pg/ml trichosanthin. (f) 
subcultured cells from culture in (c). 
/ ( J 
I I 
2.2.4. Discussion 
The inadequate selectivity of most conventional 
chemical anti-tumour drugs is well known (Ramkin & Kaye, 
1990) and their toxicity to normal cell, especially from 
renewal tissue is dose limiting (Cline & Haskell, 1980). 
When clinically used as an abortifacient agent, 
} . , 
trichosanthin has shown to 'not affect hemopoeitic system 
L / 
and associated with few side effects as mentioned in 
Section 1.6 (Liu et al., 1985; Jin, 1985). Therefore its 
cytotoxicity to some human tumour cells has therapeutic 
potential especially compared with those conventional 
anti-tumour drugs that signif icantly cause bone marrow 
suppression and other normal cell renewal (Dimitrov & 
Nodine, 1974; Cline & Haskell, 1980). 
According to the results obtained from cell protein 
content assay as described in Section 2.1, the 
sensitivity of four human cell lines (Jar, CC3, aCC1 and 
Fib1) to trichosanthin was different. Jar and CC3 are 
sensitive to trichosanthin, while aCC1 and Fib1 are 
insensitive. Based on the IC50 values of trichosanthin 
towards these cell lines, concentrations of 4 and 8 
119/ml of trichosanthin were chosen for the co-culture 
I II 
X -i lll n - i n t h is t u d y. 
I n mi x ed c ul t u re of J a r and Fibl, whe n treated with 
t r ic hosa n t h i n f o r 48 h at a concen t ration of 4 J-lg/ ml 
(near t o i t s IC SO for in vitro test of Jar cell line), 
then was hed clean of trichosanthin and subcultured, all 
t he J ar cells had disappeared while Fibl cells remained 
al ive. This result confirms the selective cytotoxicity 
of t ri cho santhin against Jar cells. In co-culture of 
CC3 with Fibl, when treated with 4 j.1g/ml of 
trichosanthin (around SO~ of IC SO value for CC3 in 
single line testing), a few of CC) cells were still 
alive. When the dose of tr ichosanthin increased to 8 
J-Ig / ml (nearly equal to its IC SO value), all CC3 cells 
died. In co-culture of oeel with Fibl exposure to 
trichosanthin, even at 8 J-Ig/ml, did not cause all OCCl 
cells to die. Fibl cells in all three co-culture 
systems continued growing healthily after treatment with 
both 4 and 8 J-Ig/ml of trichosanthin. Therefore the 
results show that trichosanthin exhibits greater 
cytotoxicity towards Jar and CC3 cell lines, but normal 
fibroblasts and OCCl cells ·are comparatively resistant 
to its efects. The sensitivities of these four cell 
lines towards trichosanthin are the same as obtained 
fr o m tes t s in single cell line culture. These results 
t t h at : 
( 1) Trichosa n t h i n has se l ect ive a c tiv it y 
c rtai n huma n t umo ur c e ll lines. 
I j J 
against 
( 2 ) There are differential responses in d i fferen t 
huma n t umo u r cell lines towards trichosanthin. 
( 3 ) The introduction of normal fibroblast cell onto 
tumour cell culture does not affect the sensitivity of 
t hese tumour cells towards trichosanthin. 
It must note that in the co-culture system, it is 
not possible to determine the exact number of various 
tumour cells and normal fibroblasts in cultures after 
the addition of trichosanthin, but this co-culture 
system should prove useful for studies on selective 
effec t s of various drugs on tumour cells (Xiong et al., 
1981; Tsao et al., 1986; Wilson et al., 1987). 
il l) 
2 . 3 'ombi n ation Effects o f Tricho s a nt h in with 
Ad r i a my c in a nd Ci s platin on 
Cultured Tumour Cell s 
2.3.1 Introduction 
Studies in cance r chemotherapy have largely aimed 
at a more rational use of established cytotoxic agents 
either singly or in combination (Cline & Haskell, 1980). 
It is obvious that combination of drugs provide the 
optimal treatment for many kinds of tumour (Frei, 1972). 
Trichosanthin has been shown to have cytotoxic activity 
against several tumour cell lines as described in 
section 2.1, and this offers an opportunity to assess 
\.,rhether it can potentiate the effect of conventional 
chemotherapeutic agents. In this study, observations 
were made to determine whether combined use of 
trichosanthin with adriamycin (ADR) or cisplatin (CIS) 
has a synergistic inhibitory effect in vitro on the 
growth of human choriocarcinoma (Jar) cells and cervical 
carcinoma (HeLa) cells. 
HI 
2 . 3 . 2 Materials a nd me thod s 
Ex perime n t al a gents 
Crystalline trichosanthin (1.2 mg/ml) was purchased 
f rom Jinshan Pharmaceutical Co., Shanghai,China. 
Ad r iamycin (doxorubicin HC1, ADR) was from Farmitalia 
Carlo Erba Ltd. , Italy. Cisplatin (Cis-
dichlorodiaminoplatinum,CIS) was from Nippon Kayaku Co. 
Ltd., Japan. Drug solutions were freshly prepared 
before each experiment by dilution in culture medium. 
Increasing concentrations of ADR and CIS, alone or in 
combination with a fixed concentration of trichosanthin 
(2.0 or 5.0 J..1g/ml) were used for the combined drug 
experiments. 
Cell and culture condition 
The source of cell line and cell culture conditions 
were the same as that prey iously descr ibed in Section 
2 • 1 . 
III 
"yt t x icit y assay 
The d r ug cytotoxicity testing method was the same 
as t ha t described in Section 2 . 1 . Briefly, 
l og arithmically growing cells were plated out in 
triplicate at 4 x 104 cells per 15.5 mm diameter 
culture well containing 0.5 ml of culture medium. After 
24 h incubation, the cells were allowed to adhere onto 
the \.Jells and to achieve around 50% confluency before 
use. These growing cells were exposed to trichosanthin 
alone or in combination with ADR or CIS in a range of 
concentrations, and incubated at 37°C for 24 h or 48 h. 
After incubation, the wells were washed twice with 
phosphate buffered saline (pH 7.4) to remove the 
detached cells and cellular debris. Cells were then 
dissolved in 1 M NaOH, and the total protein content was 
determined using a modif ication of Lowry' s method as 
previously described in Section 2.1. The growth 
inhibition activities of trichosanthin alone and in 
combination with ADR and CIS were analysed as the rate 
of surviving cells to the untreated control (presented 
as the protein content in test/control x 100%). 
The combined effects of trichosanthin with ADR or 
CIS were tested using the modif ied method of Drewinko 
HI 
( D r \v i nk tal ., 1976 ) (A pp ndi x 2 ), e x cept t h at 
~ r t 11 nc e n t r ation s we r e u sed instead of cell count s . 
Briefl y, t he c ombined effect of two drug s was eval uated 
b y qu a n t ifying the deviation from additivi t y wh en 
s eve r al different concentrations of each drug are used. 
A s core (performance index) for each concentration was 
computed by averaging the sum of ratios of observed and 
expected cell survival for each point. This is based on 
the fact that the sum of n independent normal deviates 
is distributed normally with variance n, and eliminates 
cases in which signif icance is achieved only at one 
concentration. The absence of an overall signif icant 
deviation from the predicted response suggests neither 
synergistic nor antagonistic action, but an additive 
effect for that particular combination. 
2 . 3 . 3 Result s 
T h e dose res ponses from Jar or He La ce l ls 
simul ta neous ly exposed to trichosanthin combined wi th 
A DR or CIS i n d i fferent concentrations for either 24 h 
or 48 h we r e all similar to that predicted from the 
summa t ion of the survival fraction obtained from cells 
incubated with each drug alone. This suggests that the 
effects were neither synergistic or antagonistic, but 
additive (Table 2.3.1-8). 
(/' 
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Table 2.3.1 Anti-growth effect of trichosanthin (TCS) in 
combination with ADR against Jar tumour cells after incubation 
for 24 h (mean ± SEM; n = 3) 
Treatment 


































Table 2.3.2 Anti-growth effect of trichosanthin (TCS) in 
combination with ADR against Jar tumour cells after incubation 
of 48 h (mean ± SEM; n = 3 ) 
Treatment 













56.52±2 . 80 
54.73±7 . 44 









43.11±3 . 31 30.93 
34.05±4 . 41 25.79 
19 . 67±3 . 41 15 . 46 
26.81±2 . 17 21.39 






Table 2.3.3 Anti-growth effect of trichosanthin (TC S) i n 
combination with CIS against Jar tumour cells after incuba tion 
of 24 h (mean ± SEM; n = 3) 
Treatme nt 
TCS 2.0fJ9 / ml 
+CIS 
0.0125fJ9/ml 
0.125 fJ 9 / ml 





1. 25fJ9/ ml 
S i ngle agent 
survival 






















Table 2.3.4 Anti-growth effect of trichosanthin (TCS) in 
combination with CIS against Jar tumour cells after incubation 




































Table 2.3.5 Anti-growth effect of trichosanthin (TCS) in 
combination with ADR against HeLa tumour cells after incubation 
of 24 h (mean ± SEM; n = 3) 
Single agent Combination treatment 
Treatment survival survival fraction(%) Remark 
fraction(%) 
Observed Expected 
TCS 2.0}Jg/ml 97.37±2.65 
+ADR 
0.01}J9/ ml 94.06±6.97 85.87±2.32 91.60 
0.lP9/ml 91.65±2.49 71.94±4.28 89.25 
1.0}Jg/ml 76.03±2.58 61.64±5.19 74.03 Additive 
TCS 5.0}J9/ml 89.88±3.04 
+ADR 
0.01119/ m1 94.06±6.97 83.53±1.92 84.55 
O.l}Jg/ml 91.65±2.49 72.60±4.13 82.38 
1.0P9/ml 76.03±2.58 54.93±4.20 68.34 Additive 
------------------------------------------------------------------
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Table 2.3.6 Anti-growth effect of trichosanthin (TCS) in 
combination with ADR against HeLa tumour cells after incubation 
of 48 h (mean ± SEM; n = 3) 
Treatment 
























76 . 03±2 . 56 76.03 
68.82±2.17 72.85 
42.82±1.57 46.72 
71.75+2 . 15 66.27 
57.18±1.79 62.06 
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Table 2.3.7 Anti-growth effect of tricho s an t hin (T C S) in 
combination with CIS against HeLa tumour cells after incu b a t i on 





































Table 2.3.8 Anti-growth effect of trichosanthin (TCS) in 
combination with CIS against HeLa tumour cells after incubation 















83 . 92±2 . 64 
100 . 43±3.02 
74.74±2.13 








91 . 62±5.74 84.28 
73.37±5 . 80 62.72 
39 . 96±2.27 42.43 








The most common rationale for the use of 
chemotherapy is control of the growth of tumour cell 
population by cell kill mechanisms. A major limitation 
to this approach is the nonselectivity of 
chemotherapeutic agents (Buick, 1984). The capacity to 
use the conventional cytotoxic agents to kill tumour 
cell is limited by the effect of these drugs on critical 
normal tissues. One approach to this problem has been 
to design regimes that certain combinations of agents 
that might act synergistically on tumour cells but not 
on normal tissues (Capizzi et al., 1977 ) . The 
combination of two or more cytotoxic anti-tumour drugs, 
especially with different sites of action, will result 
in enhanced cytotoxic effects, prevention of drug 
resistance, and a reduction of side effects caused by 
each drug (Miyoshi et al., 1983). A good example is the 
MVPP regime (mustard, vincristine, procarbazine and 
prednisone) used successfully in the treatment of 
advanced Hodgkin's disease (DeVita et al., 1970). 
Therefore the activity of trichosanthin on one 
trichosanthin-sensitive cell line (Jar) and one 
trichosanthin-insensitive cell line (HeLa) were 
investigated by analysing the inhibitory effect of a 
simultaneous combination of trichosanthin with 
t1 I t" . Cl III Y i n (l\ 0 R ) 0 r c i 8 P 1 a ti n ( C IS ) i n t h i s 8 tu d Y • 
Th e ADR and CIS are two conven t i o na l 
c h e mo the rape utic agents used to treat a broad spectrum 
of solid tumours. ADR is a highly toxic drug 
(Sonado nna et al., 1969; Slum & Carter, 1974). It may 
cause severe bone marrow suppression, alopecia, 
s t omatitis, vomiting and cardiac toxicity (Ramkin & 
Kaye, 1990). It produces its tumouricidal effect by 
directly binding to DNA (DiMarco, 1975; Umezawa, 1980). 
Cisplatin (CIS), structurally, is an inorganic complex. 
It is a potent inhibitor of DNA polymerase (Sradner & 
Claridgs, 1984) It inhibits DNA synthesis to a much 
greater extent than RNA or protein synthesis, and it 
binds to DNA, causing both inter- and intra-strand cross 
linking (Gale, 1975). Nephrotoxicity has most commonly 
limited the effective use of this drug (Rozencweig et 
al., 1977; Ramkin & Kaye, 1990). Both ADR and CIS are 
known to act synergistically when administered in 
combination with various chemotherapeutic drugs (Gale et 
al., 1977; Schabel et al., 1979; Umezawa, 1980). The 
combination of trichosanthin· and ADR or CIS has shown 
additive effects with respect to cell inactivation when 
human tumour cells of the cell lines Jar and HeLa were 
treated wi t h these agents. Although only additive 
([ f ric h sa n t h i n i n combi nation with ADR or CIS 
\.; r s rved i n t his s t udy, the y a re of clinical 
interest si nce tric ho santhin already in commo n u se as a 
herbal medic ine , is known to have few side effect s (J i n, 
1985 ; Wa ng e t al, 1986). Its combined additive efficacy 
wi t h ADR or CIS suggests that it may help to reduce the 
d ose o f c onventional chemotherapeutic agents needed for 
a given patient and hence reduce the known toxic side 
effects of these drugs. 
2 . 4 Effects o f Tricho sa n t h i n on Cho riocarcinoma 
Cells I n Vi v o 
2.4.1 Introduction 
Despite the efficacy of conventional anti-cancer 
agents against choriocarcinoma, use of these agents is 
often limited by severe side effects such as 
myelosuppression, gastro-intestinal upset, hepatic and 
renal toxicity (Cline & Haskell, 1980; Ramkin & Kaye, 
1990) . 
The study of anti-tumour activity in nude or 
thymectomised mice bearing human tumour xenografts is a 
well established method of obtaining information on the 
activi t y of new drugs against specific tumours 
(Giovanella et al., 1978; Billet, et al., 1979; 
Giovanella et al., 1983). The study described in Section 
2.1 has shown that trichosanthin has significant 
inhibitory effects on human choriocarcinoma cells (Jar 
and BeWo lines) in vitro. However, data on the 
sen s i t iv i ty of choriocarcinoma in vivo to trichosanthin 
i n ly un availabl . Th is lac k [ in fo rma l i n 
t r mp d a ll e val uation of t he in v i v o a c ti v ity o f 
tr ic h s ant h i n again s t human chor iocarc i noma xe nografts 
in at hymi c nude mice. A marker for identi f y i n g 
c horioca rc inoma cells is their production and secretion 
of q u a n t i t ies of human chor ionic gonadotrophin (hCG) 
(Tak a miz a wa & Sekiya, 1984). A remarkable correlation 
between choriocarcinoma mass and blood hCG level has 
been demo nstrated (Sekiya et al., 1983). The levels of 
serum hCG in Jar tumour bear ing mice before and after 
treatment with trichosanthin were measured in order to 
assess any relationship with anti-tumour efficacy. 
2.4.2 Materials and methods 
Agent and cell culture 
The source of crystalline trichosanthin and cell 
culture conditions were the same as that previously 
described in section 2.1. 
In vivo anti-tumour effects 
'JH 
L ar i t hm i cally growing Jar cells were transf e r red 
i n to 8 t o 10 wee k old male nude mi ce (Nu/Nu) by 
s ubc u ta neous inoculation of 0.25 ml of culture medium 
co n tai n i ng approximately 5 x 106 cells into the right 
flank of the recipient mouse. After implantation the 
xenograft was maintained by subcutaneous passage. 
Tumo ur bl o cks ( 1 . 5 3 mm were subsequently 
into the right flank of 20 further nude mice. 
implanted 
The mice 
were kept under sterile conditions and given sterile 
food and water. In the present experiment Jar cell 
tumours in their third passage in nude mice was used. 
When the flank tumours attained a volume 20-50 3 mm , 
twenty mice were randomized to three treatment and one 
control groups. The mice in the treatment groups(groups 
II, III and IV) received trichosanthin 0.375, 0.75 and 
1.5 mg/kg/day, respectively over 3 consecutive days by 
intraperitoneal injection. Mice in the control group 
(group I) received the drug vehicle (normal saline) 
only. The parameters measured were tumour growth 
inhibition and life-span of mice. The volume of each 
subcutaneous tumour was monitored and measured in three 
dimensions (length, width and height) every day by the 
same observer. The tumour volume was calculated by the 
following equation where L represents tumour length, W 
t UIll u r \vid t h and H tumour thickness ex pressed i n cubic 
millimeters: 
Jt /6 x L x W x H 
The day prior to the trichosanthin injection was 
defined as day 0 of the experiment. The general well 
being (including appetite, weight loss, reactivity and 
mobility) of mice was observed daily. The survival of 
mice was estimated from observation every 6-12 h until 
they die. 
Differences in tumour volume among different 
groups were tested using analysis of variance for 
repeated measurements, differences in life span 
way analysis of variance. 
Blood hCG assay 
by one 
On the day pr ior to treatment and then on day 4 
blood samples (25 ~l) were taken from the tail vessel of 
mouse and diluted in 375 ~l 0.7 M phosphate buffer. The 
supernatants were kept at -20°C pending later assay. 
I (J{) 
81 d n ce n trati n o f hCG was deter mi n e d by 
radioimmunoass ay using hCG kits from Shang hai Institute 
of Biologic al Products, Shanghai, China . Differences i n 
blood hCG concentrations among different groups were 
tested by analysis of variance . 
I {J I 
2 .4.3 Result s 
Effect of trich osa n t h i n a gain st c h oriocarcinoma in 
vi vo 
Tr ichosanthin demonstrated marked activity on J ar 
cells in nude mice causing signif icant suppression of 
tumour growth as shown in Figure 2.4. 1. The change in 
tumour volumes has been plotted against time for each of 
the four groups in Figure 2.4.2. Tumour growth in the 
control group increased exponentially. 
of tumour growth was significant 
The inhibition 
in the three 
trichosanthin-treatment groups compared to the controls 
(p<O.OOl). No significant difference in the tumour 
volume was observed among the three treatment groups (p 
> 0.05). When the survival of the tumour-bearing animals 
was used as the endpoint of the exper iment, the mean 
survival was found to be 8.35 ± 0.5 days for the 
untreated controls (Group I) and 16.2 ± 1.7 days for the 
treatment group given a dose of 0.375 mg/kg/day 
trichosanthin (Group 11). There was no effect on body 
weight in Group 11. A dose of 0.75 mg/kg/day resulted in 
a median survival of 13.15 ± 1.5 days with weight loss 
in 1/5 mice (Group Ill). The highest dose, 1.5 
10) 
III / k / lay , r u lt d i n a s u r v i v a l of 11.00 ± 1 . 5 d a y s 
\ .J i t 11 we' g 11 t 1 0 ss i n 1 / 5 mic e ( G r 0 u p I V ) ass h Ov-I n in 
Fig u re 2 . 4 . 3 . Ther e a r e statistically sign ificant 
differe n c e s in the mean survival times among the c o n trol 
and the three trichosanthin-treated groups (p<O.Ol). 
There were no toxicity related deaths in any of the 
trichosanthin-treatment groups. 
Blood hCG concentration 
Before treatment of trichosanthin blood 
concentrations of hCG in tumour bearing mice ranged from 
98.6 to 107.8 ng/ml. There are no statistically 
differences among trichosanthin-treated groups and 
control group (p > 0.05). At Day 4 after treatment hCG 
concentration in trichosanthin-treated groups (Group 11, 
III and IV) reduced to 16.2, 11.2 and 18.2 ng/ml, 
respectively, while in untreated control group hCG 
concentration reached to 709 ng/m1. These are 
statistically different (p < 0.01) as shown in Table 
2.4.1. 
J () ) 
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FIgure 2. '1.1 I'hologrnph of humall Jar churIocarcinuma hearing 
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Figure 2.4.2 Response o( subcutaneously implanted human 
choriocarcinoma (\Jar cell line) xenografts (ollowing 
intraperiloneal lrealment with trichosanthin. Unlrealed 
cont.rol, 0--0 ; lri c hosalllhill O.J75rng/kg/day, • __ • ; 
lricllos<llllhill O. 75mg/kg/~lay, 6--6 trichos<lnthin 
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Figure 2.4.3 Life-table survival probability of nude mice 
bearing subculaneously implanted human choriocarcinoma 
(Jar cell line) treated with lrichosanthin 
intraperiloneally. Unlrealed cOlltrol, 0--0 
lri c hos(111thin O.Jo/5my/ky/day, .--. lrichosanthin 
o . 7 5 In Y / k y / day , 6. - 6 l r i ch o.s a ul h i n 1 . ~Hn g / kg / day I 
A--A 
Table 2.4.1 Effect of trichosanthin (TCS) on hCG 







p > 0.05 
b 
P < 0.01 
hCG levels in blood (ng/ml) 
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2.4.4. Discussion 
It h as be e n shown that transplan t ed malign a n t 
t umo u rs pro liferate in animals with congenital t hymus 
defic iency in a manner similar to human metastatic 
tumou r s (Fidler, 1986). This tumour model has been 
subjec ted to various experimental investigations (Billet 
et al., 1979). As the chemosensitivity of tumour tissue 
is retained after heterotransplantation, the nude animal 
model is apparently suitable for preclinical testing of 
tumouricidal activity of newly developed cytotoxic 
agent s (Kopf -Maier, 1989). The predictive therapeutic 
value for human patients seems to be high, with the 
probability of correct prediction of tumour response or 
resistance ranging between 92% and 97% (Fiebig and Lohr, 
1984) . 
Trichosanthin has been shown to have marked 
cytotoxic activity in vitro against different tumour 
cell lines as described in Section 2.1. In this study 
trichosanthin has shown its therapeutic efficacy against 
human choriocarcinoma (Jar) xenografts with tumour 
growth inhibition, prolongation of survival of tumour-
bearing mice and decrease of blood heG concentration, 
suggesting that trichosanthin is effective against human 
) () H 
II to i a 0 ' i n ma . T h is pr o v i d es f u rt h er laboratory 
li p r f r c li ni ca l st ud ies i n t h e u se of 
t r ic hosant h i n. 
The dos e o f trichosanthin treatment of xenografted 
t umours i n nude mice was arbitrarily designed according 
t o t he previo usly reported LD50 value. Groups of 10 
no r mal female mice (18-22 g body weight) were treated 
with 5 g r aded doses of crystalline trichosanthin 
subcu t aneously. The number of died mice was recorded in 
each dose group for 10 days. The 50% lethal dose 
( LDS O) calculated from the results of 5 experiments, is 
0 .236 mgjanimal (around 13.4 mgjkg) (Jin et al., 1981; 
Xiong et al., 1988). A schedule with daily injections 
during 3 days was used, because in vitro data showed a 
time-dependent inhibitory effect of trichosanthin on 
gro wth of Jar cells. After 3 days trichosanthin 
treatment, it was observed that the mice had a reduced 
appetite, lost weight, blunted reactivity and mobility 
in 1 of 5 mice in Group III and 1 of 5 mice in group IV, 
suggesting the mice could not tolerate the adverse 
effects of these dosages of trichosanthin. In Group 11, 
given trichosanthin 0.375 mgjkg for 3 consecutive days, 
no mi ce exhibited weight loss or changes of reactivity 
and mob ili t y. This eliminates the possibility that the 
J ( J ' ) 
um Ut" l 1: \.JL h i nh ibition may be due to t xi c e ff ect o n 
t h h t (H ia n & Fu r u sawa , 1987 ), a nd indicate s that 
t h i r gim is effect ive a nd safe . Fu rther testing o f 
t h e effect o f t r ichosan t hin i n do ses be l o w 0. 375 
mg j kgjday ma y be helpful in establishing a the rape utic 
win d o \ .J 0 f t r i c h 0 san t h in a 9 a ins t x e nog r aft e d hum a n 
chor i ocarcino ma in mice. 
In conclusion, trichosanthin caused significant 
regression of pre-existing Jar choriocarcinoma tumour 
and a reduction in overall mortality in tumour bearing 
mice. These findings prov ide additional support for 
t h e possible role of trichosanthin in the treatment of 
of patients with choriocarcinoma. 
I I () 
2.5 Effects of Trichosanthin Protein and Polysaccha r ide 
on Choriocarcinoma Cells I n Vitro 
2.5.1 Introduction 
Tr ichosanthin is extracted and pur if ied from the 
Chinese . herb T ian Hua Fen, the root tuber of 
Trichosanthes kirilowii Maxim of Cucurbitaceae family 
(Wang, et al., 1986). In an effort to increase the 
success rate and minimize side effects in abortion 
induced by trichosanthin, its preparation from crude 
extract has been developed through three stages (Tian, 
1988). Crude preparation (crude trichosanthin) from the 
plant comprises 40-50% protein. Acetone fractionation 
results in a refined product (refined trichosanthin) 
made up of 80% protein. Crystallization of the acetone 
preparation produced a preparation (crystalline 
trichosanthin) with more than 99% protein. Clinically 
it has been suggested that the protein may be the 
component causing abortion in the trichosanthin 
preparations (Anon., 1976a; Tian, 1988). The potency of 
these preparations in the induction of mid-trimester 
abortion increases with the amount of protein in the 
I I I 
pr para to n a nd abortion is ac h ieved in over 9 5 1; o f 
cas s by usi ng i n tramu sc u lar doses of 5, 2 , a nd 1 . 2 mg 
of cr u de , ref in e d and crystalline tr ic h os an t h in 
respecti vel y (Tian, 1988). In order to examine whe t her 
t he i nh ibi t o ry effects on the growth of tumour cells in 
v itro (see Section 2.1) is also from the protein 
c o mponents in the trichosanthin preparations, the 
potency of two trichosanthin preparations refined 
tr ichosanthin (containing 80% protein) and crystall ine 
trichosanthin (containing 99% protein), against human 
choriocarcinoma cell line Jar was compared in this 
study. 
It was recently reported that many polysaccharides 
separated from bacterial walls and plant medicine have 
an anti-tumour action (Gu and Gu, 1988) and enhance the 
anti-tumour effects of chemotherapeutic drugs when used 
in combination (Zhang, 1987). The refined trichosanthin 
and crystalline trichosanthin contain 1-10% and 0.2-0.5% 
polysaccharide respectively. A trichosanthin 
polysaccharide - Tian Hua Fen polysaccharide (THFPS) has 
been purified during the preparation of crystalline 
trichosanthin (Tian et al., 1985). Therefore in this 
study, the effect of THFPS alone or in combination with 
crystalline trichosanthin on human choriocarcinoma cell 
line (Jar cell) was also studied. 
I I ) 
2 . 5 . 2 . Material s and method s 
Agen t s and J ar cell cultur e 
Refi ned t richosanthin (containing 80 % protein) and 
t r i c ho s anthin polysaccharide Tian Hua Fen 
polysaccharide (THFPS) were prepared by the Shanghai 
Institute of Organic Chemistry. Crystalline 
trichosanth i n (Batch No.881220) (containing 99 % protein) 
was pu r chased from Jinshan Pharmaceutical Co., Shanghai, 
China. The Jar cell culture conditions were the same as 
that previously described in Section 2.1. 
Jar cell inhibitory test 
. Logarithmically growing Jar cells were plated out 
in triplicate at 4 x 104 cells per 15.5 mm diameter 
well containing 0.5 ml of RPMI1640 medium in 24-well 
culture plates (Corning, NY, USA). After 24 h 
incubation, the cells adhered onto the wells and 
achieved around 50% confluence before use. These 
growing cells were exposed to either (l) crystalline 
trichosanthin, re f ined t r i c hosanthin or THFPS alone, or 
J J I 
( 4 . ) t-ys -alli n tri h sa n t ld n c mbi n d wit h T H FP S n a 
1: n f n e ntrat i o n s , a nd i nc ub a t e d for 48 h at 37°C . 
T h \v 11 s we re t he n was he d t w i c e w it h ph 0 s p h a t e b u f f e red 
sa l i ne (pH 7.4) to remove detached cells and cellula r 
d e bris. Cells which remained attached to culture wells 
were mainly surviving viable cells, which were then 
dissolved in 1 M NaOH, and the total protein content was 
determined using a modif ication of Lowry' s method as 
previously described in Section 2.1. The cytotoxic 
activities of the agents alone and in combination were 
analysed as the ratio of surviving cells to untreated 
control (presented as the protein content in 
test/control x 100%). The concentration-response curves 
were plot ted. The inhibitory concentration (IC50 ) was 
determined as the concentration leading to 50% 
inhibition of the cell population. This was used to 
compare the relative efficacies of the agent towards the 
cell line. 
The combined effects of crystalline trichosanthin 
with THFPS were evaluated using the modified Drewinko's 
method (Drewinko et al., 1976) (Appendix 2) as the same 
as that described in Section 2.3. 
2 . 5 . 3 Res ul ts 
The inh i bitor y effects of these three agen t s o n J ar 
cells were d ose d e pendent as shown in Figure 2.5.1. The 
I C50 was 3.3 I1g/ml for crystalline trichosanthin, 16.0 
I1g/m l for refined trichosanthin and 70.0 ~g/ml for 
THFPS. 
The survival fraction of Jar cells simultaneously 
exposed to crystalline trichosanthin and THFPS was lower 
than that with either agent alone, but there was no 
significant deviation of the observed effect from the 
expected effect, i . e. , neither synergistic nor 
antagonistic effects could be demonstrated. Therefore 
the observed cytotoxic action of combined crystalline 







































Effects of crystalline trichosallthin (0), 
refined trichosAnthin (.) and Tian HUA Fen polysaccharide 
( ... ) on the growth of JAr cells ill vitro after 48 h 
incubation (means ± SEM, ,n' = 3). 
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Tabl e 2 . 5. 1 Anti-g r owth e ffect of T i an Hu a Fe n pol y saccharide 
( THFPS) i n combination with crystalline tr i chosanth in ( TCS) 
a g a inst Jar choriocarcinoma cells after 48 h incubation ( means ± 
SEM, n = 3). 
Tr eatment 
THFPS 2.0f1g/ ml 
+crystalline TCS 
0 . 2j.1g/ml 
2 . 0j.1g/ml 
20.0j.1g/ml 
















32 . 8±1.5 
85 . 2±1 . 1 
70.2±1 . 6 







survival fraction( %) Remark 
Observed Expected 
67 . 8±3 . 0 63 . 6 
53.7±2 . 2 50 . 8 
25 . 6±1 . 8 29 . 7 Additive 
60.2±1 . 1 59.8 
49 . 8±3 . 8 47.8 
23 . 5±1.9 28.0 Additive 
48.1±1.8 49.3 
40.1±1.7 39.4 
22.2±1.6 23.0 Additive 
------------------------------------------------------------------
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2 . 5 .4 Disc u s sion 
Cl i ni c ally i t has been shown that the abortifa c i e n t 
pote n cy of trichosanthin preparations posit i ve l y 
correlates with their protein content (Tian, 1988) . 
The r e fo re it is supposed that the abortifacient action 
is fr om protein component (Xiong, 1988). This study 
showed the IC SO value of crystalline trichosanthin was 
lower than that of refined trichosanthin for inhibiting 
growth of Jar cells in vitro, while the protein content 
(99%) in crystalline trichosanthin is higher than that 
(80 %) in ref ined trichosanthin. This suggests that 
similar to the abortifacient potency the primary effect 
against choriocarcinoma cells possibly is from the 
protein component of trichosanthin. 
Results also show that THFPS would inhibit 
choriocarcinoma cell growth in vitro only at high doses. 
The simultaneous exposure to both THFPS and crystalline 
trichosanthin shows an additive effects against the 
growth of Jar cells in vitro in this study. However, 
many experiments have indicated that the effects of 
polysaccharides against tumours were mediated by 
enhanc ing immune responses (Gu & Gu, 1988; Chihara et 
I I H 
( L. , 1 'J 0 ; Fu j i i tal ., 1979 ). For i n s t a nce , b t h 
Ging n polysa c ll aride and mushroom polysaccharid e 
(Lentinu1Tl ) give n in traper i to ne a lly inhib it t he growth of 
S- 180 sa r coma in mice, however, they have not shown 
d irect cyt o t oxicity against tumour cells in vitro 
( Zha ng , 19 8 7). Gingsen polysaccharide is a significant 
st i mul an t of the immune function of the organism (Gu & 
Gu, 1 988), and mushroom polysacchar ide is capable of 
induc i ng the production of interferon in body in 
addition to enhance the immune functions indispensable 
to the organism ' s defense against tumour growth (Zhang, 
1987). Therefore, it is worthwhile to investigate the 
effect of THFPS on the immune function of body and the 
growth of tumour cells in vivo. If this is indeed so, 
trichosanthin in combination with THFPS should have a 
more prominent immunomodulatory action than 
trichosanthin alone in vivo. 
I I f ) 
Chapt e r 3 Mechanism of Action of Trichosanthin on 
Tumour Cells 
This chapter describes aspects of mechanism of 
cytotoxic action of trichosanthin, including the 
morphological changes of cultured trichosanthin-
sensitive choriocarcinoma cells after treatment with 
trichosanthin (Section 3.1); the in vitro study of 
trichosanthin binding to tumour cells (Section 3.2) and 
the effects of trichosanthin on macromolecule synthesis 
in intact choriocarcinoma cells (Section 3.3). 
I )I! 
3.1 t-1orphological study of Effects of Trichosanthin on 
Cultured Choriocarcinoma Cells 
3.1.1 Introduction 
Although trichosanthin has been shown to have 
cytotoxic activity against several tumour cell lines, 
being selectively more active towards choriocarcinoma 
cells as shown in Section 2.1. The mechanism of action 
of trichosanthin has not yet been fully elucidated. 
In order to investigate the mode of action of 
trichosanthin on tumour cells, this study was undertaken 
to examine the morphological changes of cultured 
trichosanthin-sensitive human choriocarcinoma (Jar) 
cells after treatment by trichosanthin using light and 
electron microscopy. Special attention was devoted to 
their ultrastructural features. 
I ) I 
3.1. 2 . Mat e rials and methods 
Ex per i me ntal agent and cell culture 
The source of crystall ine tr ichosanthin and cell 
culture conditions were the same as that previously 
described in Section 2.1. 
Light microscopy 
The logarithmically growing Jar cells were plated 
onto coverslips for 48 hours. The cells were further 
incubated with or without trichosanthin (4 ~g/ml) for 8 
or 24 h. Specimens were fixed with formalin, stained 
with haematoxylin and eosin (H & E) and examined under 
light microscope. 
Electron microscopy 
The Jar cells (1 x 10 5 cells/dish) were grown in 
35 mm diameter culture dishes (Corning, N.Y., USA) with 
collagen gel at 37°C. After 48 hours, the cells were 
I II 
. t· a · e d \". h 0 r wit h L1 t t r i c h san t h i n ( 11 f.1 9 / m 1 ) t r 
diff r n t time i n ter v a l s . The samp l es were rinsed 
several times wi t h p hos p hate buftered saline ( p H 7.4) at 
37 ° C a nd f ixe d in situ with 2.5 % glutaraldehyde in 0 . 1 
M sod i um c a c odylate (pH 7.4) at 4°C for 1 h. Fo r 
transmi s sio n electron microscopy, the specimens were 
then post- f ixed for 1 hour in 1% osmium tetroxide in the 
same buffer, following which they were washed in 
phosphate buffered saline (pH 7.4), dehydrated and 
embedded in Spurr resin. Ultrathin sections were 
stained with uranyl acetate and lead citrate and 
examined with a JEOL 100 CX 11 electron microscope at 
80 kV. For scanning electron microscopy, the fixed cells 
were rinsed, dehydrated, cr i tical point dr ied, coated 
with gold-palladium and examined with a JEOL 35-CF 
scanning electron microscope at 15 kV. 
Preparation of collagen gel 
Collagen was prepared from rat tail tendons. Tails 
from mature rats were cut off and collected in 75% 
ethanol. After draining of the ethanol, the tails were 
cut into pieces and collagen fibers were dissected out 
and weight. The tendons were extracted with 30 ml per 
I I I 
l" e m l:lOO 0 . 5 M a etic acid at 4°C for 2 d a y s . 'rh 
lla n solution was then centrifuged at 2,300 g f o r 2 
days at the same temperature. The clear supernatant was 
poured of f and stored in sterile bottle at 4°C for 
future use. A gel of native collagen fibers was formed 
in a 35 mm diameter sterile dish by rapidly mixing 0.85 
ml of collagen solution with 0.2 ml of 10 x F10 medium 
and 0.3 M NaOH (2:1 v/v). The mixture was left for 30 
seconds to harden and was then sterilized by ultraviolet 
irradiation for 15 min (Schor, 1980). Culture medium 
was then added to equilibrate the gel overnight in a 
37°C CO2 incubator. 
Apoptotic index 
The apoptotic index was defined as the percentage 
of Jar cells in H & E staining showing early apoptotic 
changes (such as condensation and margination of the 
nuclear chromatin) after exposure to trichosanthin for 8 
or 24 h. 
3.1.3. Re sults 
Ligh t microscopy of Jar cells 
Scattered single cell showing apoptotic changes 
c ould be seen among Jar cells after exposure to 
trichosanthin. Cells in the early stage of apoptosis 
could be recognized by the striking condensation and 
margination of their nuclear chromatin(Figures 3.1.1b 
and c). The later stages of apoptosis were represented 
in the form of membrane bound rounded cellular bodies 
(apoptotic bodies), which typically contained one or 
more dense nuclear fragments (Figures 3.1. I-d) . The 
apoptotic indexes the average over 50 high power 
fields examined) were 0.5%, 2.4 % and 14.6% in untreated 
control, after 8 h trichosanthin-treatment and 24 h 
trichosanthin-treatment, respectively. 
Electron microscopy of Jar cells 
In scanning electron microscopic studies, after 
treatment with trichosanthin for 8 h, the cell surface 
of intact Jar cells remained covered with microvilli, 
J /') 
\,., 11 L 1 11 und rg ing ap ptosis show d relativ ly 
Sill t h surfa'e prot ubera nces of various sizes (Figure 
. 1 . 2 ). In Jar cells treated with trichosanthin for 24 
h, the foca l s urface protrusion was more prominent 
(Figure 3.1.3). In transmission electron microscopic 
studies, affected cells showed a spectrum of 
ultrastructural appearances (Figures 3.1.4-6) reflecting 
the sequence of morphological changes that occurs during 
the apoptotic process. In earlier stages, microvilli 
began to disappear, but blunt protuberances were formed 
on the surface(Figure 3.1.4). Membrane-bounded 
apoptotic bodies resulting from Jar cell fragmentation 
were frequently seen. These had well-preserved 
cytoplasmic organelles and usually one or more nuclear 
fragments with characteristic chromatin segregation 
(Figure 3.1.5). Intracellular apoptotic bodies could be 
demonstrated after they had been ingested by intact Jar 




























Figure 3.1.1 Light microscopic appearances of Jar cells 
(H and E x 400). (a)Controli (b) after 8 h 
trichosanthin-treatment. Cells with early apoptotic 






Figure 3.1.1 Light microscope appearances of Jar cells 
(H and E x 400). (c) and (d) after 24 h 
tr ichosanthin-treatment. Cells with early apoptotic 
changes are indicated by arrow, while apoptotic bodies 
with nuclear fragments are indicated by double arrows. 
I ') / 
Figure 3.1.2 Scanning electron microscopic photograph 
of Jar cells treated with trichosanthin for 8 h. The 
surface of normal ' cells is covered by microvilli, 
whereas cells undergoing apoptosis show relatively 
smooth surface protuberances of various sizes. (Bar = 
3 ~m) 
I J i~ 
Figure 3.1.3 Scanning electron microscopic photograph 
of Jar cells treated with trichosanthin for 24 h. The 
focal surface protrusion and membrane distortion are 
very prominent. (Bar = 5 pm) 
Figure 3.1.4 Transmission electron microscopic 
photograph of early cytoplasmic changes of apoptosis 
in Jar cell after 8 h treatment with trichosanthin. 
Note the appearances of blunt protuberance (A) on the 
surface. (Bar 1 pm) 
I j() 
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Figure 3.1.5 Transmission electron microscopic 
photograph of Jar cells after 24 h treatment with 
trichosanthin. Apoptotic body (A) and lipid droplets 
(L) are present. (Bar = 1 pm) 
I ~ I 
Figure 3.1.6 Phagocytosed apoptotic body (A) within a 
Jar cell after 24 h trichosanthin treatment. (Bar = 
1 pm) 
III 
3 .1. 4 . Dis u ssioll 
I I 
J I 
l\ lt ho u h In c h a n isms o f ce l l deat h are not yet fully 
un derstood , two c l earl y di sting uishable type s , 
ap ptosis a nd nec r os i s , have b e en suggested (Wyllie, 
19 8 1 ; Ker r et al., 198 4 ). Results of this study suggest 
t hat apoptosi s is an important form of Jar cell death 
fol l owing tric ho san t hin treatment. The observable death 
of Jar cel ls treated by trichosanthin, correlated well 
with the length of trichosanthin exposure. 
The sequence of events in cells dying by apoptosis 
wa s desc r i bed by Kerr et al. (1987). Briefly, the 
ear liest c h a nge is a condensation and segrega~ion of 
chr om a ti n i nto sharply delineated masses that lay 
agains t the nuclear membrane. After a ser ies of 
c hanges inc lud ing cytoplasmic condensation and nuclear 
fragmen t at io n the cells break up into a cluster of 
me mbrane-bo unded apoptotic bodies in which the integrity 
o f organe ll e s is initially maintained. The apoptotic 
bodies are then r apidly phagocytosed by surrounding 
viabl e tumour cells . 
T h n ri 9 f hrtn s wh i ' h t 9 t h r make up th 
h n III n n f a ptosis are remar kab ly constant i n a 
\..; i e r ng of cel l type a nd i n deat h s trigged b y a 
v a rie t y of st i mul i (Wyllie, 1987). l\poptos is is the 
mo de of cell deletion in hormone-dependent, normal cell 
turnove r, and the targets of cell killing by cytotox i c T 
cells (Kerr et al., 1972; Ferguson & Anderson, 1981; 
Ouvall & Wyllie, 1986; Stacey et al., 1985). Searle et 
al. (1974) investigated the mode of cell death induced 
by four tumour-chemotherapeutic agents, i . e . , 
actinomycin 0, mitomycin C, cytosine arabinoside and 
cycloheximide, each with a different mechanism of 
chemical action, in the Crocher mouse sarcoma 180 
(Stewart et al., 1959) growing as an ascites tumour. 
Examination of smears of tumours from control animals 
showed that apoptosis bodies were always present, the 
proportion of these bodies to intact cells ranging from 
0.5-1%. In the 24 h following single injection of each 
of the drug, there was a marked and progressive increase 
in the number of apoptotic body, the ratio of this 
apoptotic body to intact tumour cell reaching 20%. This 
indicates that each of the tumour-chemotherapeutic 
agents used could markedly enhance apoptosis in ascites. 
Oucan & Heddle (1984) observed a dose-related increase 
in apo p toti c body of colonic crypts to mice ingested 
J \ ' , 
\v i.. t Il k 11 Hv 11 . nil i . t [ . 
" l " r s 0 pr L .L 11 s ynthesis , d iph t h ria 
x i n r- pur my c in. Griffit h s et al . ( 1987 ) r e por t ed 
t h ff - s f plant protei n toxins ricin and abrin o n 
mamma l ian lymphoid tissues. Most striking was also 
lymphoid c el l apoptosis. 80th ricin and abrin inhibit 
protei n synthesis in eukaryotic cells. These 
observations, thus, wo uld imply that the initiating 
stimuli of apoptosis may vary widely and the mechanisms 
involved in reception of these stimuli are also 
heterogeneous (Gehring & Collino, 1977). 
In vie\v of the fact that trichosanthin was also 
shown to be potent inhibition of protein synthesis 
(Xiong et al., 1980; Wang et al., 1986; Yeung et al., 
1988; also see below Section 3.3), it is likely to cause 
apoptosis by a mechanism similar to that induced by 
above protein synthesis inhibitors. It assumes that 
these inhibitors cause the disruption of the cell 
cytoskeleton resulting in characteristic blebbing of the 
plasma membrane. This feature is well demonstrated in 
a study on ricin poisoned hepatoma cell and rat 
hepatocytes (Creppy et al., 1981). In a recent review, 
Duvall & Wyllie (1986) further suggested that the 
sever ity of cell membrane damage might determine the 
mode of cell death so that apoptosis might result from 
mildly disruptive damage, while severe damage causes 
I \ 1, 
I\ t ' s i s . I f i n h r ioca r: c ino ma growt h i nh ibited by 
t ri h santhin, tumour cells die as a re s ult of 
inhibition of protein synthesis, the one might expect 
perturbations of me mbrane structure by depletion of 
integral membrane proteins to be a gradual effect. This 
mildly disruptive damage would be therefore expected to 
cause apoptosis rather than necrosis . 
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3 . 2 Bi nding o f Ra d i ol a b e ll e d Trichosant h in with 
Tumour Cells I n Vitro 
3.2.1 Introduction 
Many proteins of diverse physiological and 
pathological activities are known to enter various cell 
compartments by receptor-mediated transport processes 
(Chang & Neville, 1978; Pastan and Willingham, 1985). 
Whether trichosanthin, a basic protein, exerts its 
cytotoxic effects after binding to specific membrane 
receptors in its target cells is worth investigating in 
order to understand its mechanism of cytotoxic action. 
It is the purpose of the present investigation to 
examine the existence of trichosanthin receptor in 
sensitive tumour cells using 125r-labelled crystalline 
trichosanthin. The binding of 125 . h th' I-tr1c osan 1n to 
trichosanthin-sensitive human choriocarcinoma (Jar) 
cells and trichosanthin-insensitive cervical carcinoma 
(HeLa) cells was examined to explore whether there are 
specific receptors of trichosanthin in these target 
cells. 
. 2 . 2 . "'a t r i al s and method s 
Ex perime n ta l a g e n t s 
Th e sou rc e of crystalline trichosanthin is the same 
a s tha t d e scribe d in section 2.1 . Carrier-free 
125 . d· 1.0 1.ne in NaOH (100 mCi/ml,IMS.30) was from Amersham 
International, PLC, UK . Anti-trichosanthin antibody 
was kindly offered by Or M. Yie and Or Y . Y. Ji, Shanghai 
Institute of Cell Biology, Shanghai, China. Bovine serum 
albumin was from Sigma Chemical Co ., USA . 
Cell culture 
The culture of choriocarcinoma Jar cell and 
cervical carcinoma HeLa cell was the same as that 
previously described in section 2 . 1. 
Labelling of trichosanthin 
T h d in ~ 1 11 [ L t o 0 h R Cl n L h i n f 110 ItJ 8 t h e 1 n L h 0 
d rib ly Sa l ac in s k i (1 981 ) wi t h modifi c a i o n s . 
I ni ti lly 1 mg 1,3,4,6-t e trachl oro - 3 , 6 - d i p h e n yl 
glyco luril (Idogen), a solid-phase oxidizing agent, was 
dissolve d in 25 ml dichloromethane, and 50 /-1 1 of t h i s 
s o luti o n was dispersed in the bottom of a polypropylene 
i o dina t i o n vial and evaporated to dryness at room 
tempera t ure under nitrogen. This removed the 
di c hloromethane and produced a film of Idogen. Sodium 
phosphate buffer (0.05 H, 10 /-11, pH 7.4) was added to 
the iodination, followed by 125 r - Na (1 mei, 50 /-1 m , 10 /-1 1 ) 
and 120 /-1g tr ichosanthin (in 100 /-11 of 0.05 H sodium 
phosphate buffer, pH 7.4). The iodination was allowed 
to proceed for 10 min, and terminated by adding 500 /-1 1 
of protein-free 0.05 H sodium phosphate buffer. The 
diluted mixture was left standing for a further 15 min 
at room temperature, before loading onto a column of 
Sephadex G-50 (1.5 x 50 cm ) which was developed at 1 
mlj3 min. Fractions (0.5 ml) were collected and counted 
on a gamma counter. Two well separated radioactive peaks 
were observed (F igure 3.2.1), the first of which was 
pooled as tracer. The tracer prepared ran as a single 
band on sodium dodecyl sulphate-polyacrylamide gel 
electrophoresis and possessed the same mobility as 
unlabelled trichosanthin. The radioactivity of the 
tracer in this band was also demonstrated by 
I I t! ) 
Ll 1- II :l i rap h y ( Fig Ll re 3 . 2 . 2 ) . Th is tracer was 95'~; 
pr i~itable b y co l d 10 ' tric hl oroacetic acid , 95~ 
precipitabl e using a n t i-tri c h o san t hin ant i b o dy an d had 
a spec i f i c a c t i vi t y by r adioimmunoassay of abo u t 100 
J..lC i / mg . 
The biological activity of the labelled 
trichosanthin was also tested. This was done by 
measuring the abili t y to inhibit the growth of Jar cells 
in vitro using the previously described method in 
Section 2.1. It can be seen from Figure 3.2.3 that 
there '..Jas no significant difference in the cytotoxic 
activity of the original trichosanthin compared to that 
which had been labelled with 125 1 by the Idogen method. 
Binding assay 
The following procedure was used in the initial 
experiments for measuring the binding of iodinated 
trichosanthin by Jar and HeLa cells in suspension. The 
logarithmically growing cells were trypsinized using 
0.25 ~ trypsin (w/v) and washed twice with binding 
buff er c o ntaining 15 mM 3-(N-morpholino) 
/ 11 / 
a i I, 15 mM NaCl , 5 mM glu 'o se a nd 1 '~ 
vi n c um al bum i n, p H 7.6. Th e s u s pensio n wa s 
h n n - r if u ged for 5 min a t 110 g. Triplicate tubes 
n tai n i ng 1 x 10 6 ce ll s e a c h were inc ubated f or 1 h 
at 3 7 °C wi t h 0.5 ml of binding buffer containing a range 
of 2.5 x 10 4 to 80 x 10 4 cpm f 125r t 'h h ' o - rlC osant In 
with o r witho ut 60 ~g/ml unlabelled trichosanthin. The 
c ells were then washed three times with ice-cold 
phosphate- buffered saline (pH 7.4 ), and bound 125 r _ 
tricho santhin was quantified in a gamma counter (Packard 
Auto-Gamma 5650, United Technologies, USA). 
After the initial experiments, the protocol for 
measuring binding of radioactive trichosanthin was 
modified to use cells in monolayers. The 
logarithmically growing cells were first plated out at 1 
x 10 5 cells per 15.5 mm diameter culture well containing 
0.5 ml of culture medium. After 24 h incubation, the 
cell monolayers were washed twice with binding buffer, 
and exposed in triplicate to 125r-trichosanthin at 
different concentrations with or without 60 pg/ml 
unlabelled trichosanthin for 1 h at 37°C. They were 
then washed three times with ice-cold phosphate 
b ff d l ' e (pH 7 4) and d~gested with 1 M NaOH. u ere sa I n . -'-
1/1/ 
r l " i 11 \v _ r 
- h 11 as a y I ( r r adi acti v it y . 
To st u d y t he kineti c s of associat ion of 1 2 5 1 _ 
t r i c hosa n t hin to c ultu r ed Jar cells, triplica te tube s 
ea c h co ntai ning 1 x 10 6 cells were incubated at 37° C 
with 0 .5 ml b ind ing buf f er containing 10 x 10 4 cpm 125 1 _ 
trichosanthin for different time intervals. To 
investigate the kinetics of dissociation, triplicate 
samples \vere incubated with 0.5 ml binding buffer 
contain i ng 10 x 10 4 cpm 125 t ' h th ' 1- r~c osan ~n at 
for 3 h to ensure maximal binding and then the cells 
were washed three times with ice-cold binding buffer so 
that unbound 125r-trichosanthin was removed. Finally 
they were incubated at 37°C with or without 60 1-l9/ml 
unla belled trichosanthin for various periods of time. 
At the end of each incubation period, all samples were 
washed three times with ice-cold phosphate-buffered 
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Figure 3.2.2 Sodium dodecyl polyacrylamide gel 
electrophoresis of unlabelled (IJane ]) and 1251 - 1abelled 
(Lane 2) trichosanthin, and autoradiography of 125 1 _ 
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3.2.3 Results 
Saturation and reversibility of radiolabelled 
trichosanthin binding 
The effects of the concentration of radiolabelled 
trichosanthin on the level of association with Jar and 
HeLa cells in suspensions are shown in Figures 3.2.4 and 
3.2.5 respectively. The association increased as the 
trichosanthin concentration was increased to a level of 
cpm, but saturation was not achieved. 
However, when excess unlabelled trichosanthin was 
present the association was still observed, but its 
magnitude was almost equal to the degree of association 
without unlabelled trichosanthin. Control experiments 
with culture tubes containing binding buffer (no cells) 
demonstrated the absence of radiolabelled trichosanthin 
binding to the cul ture tube surface. The binding of 
125r-trichosanthin to Jar or HeLa cells in monolayers 
was also unsaturable and not significantly inhibited by 
excess unlabelled trichosanthin (Figures 3.2.6 and 
3.2.7). 
Kinetics of radiolabelled trichosanthin binding 
T est imate the kin e tics of associ a ti o n an d 
dissociat i o n of t richosanthin with Jar c e lls, bou nd 
1 2 5r- t ri c ho santhin levels were measured a s a funct i o n of 
time. Figure 3.2.8 shows that bound 125I-trichosanthin 
levels in Jar cells incr~ase quickly to reach a plateau 
after 15 min at 37°C. Figure 3.2.9 shows that a 
1 t f b d 125 t . h th' P a eau 0 oun 1- r~c osan ~n levels was seen in 
Jar cells when followed over a 4 h period at 37° C, the 
radioactive uptake by Jar cells was nearly the same 
whether measured in the p'resence of excess unlabelled 
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Figure 3.2.9 Klnelicn ot dissociation ot 12S1-t:richosanthin 
wilh Jar cellfJ. IL5J - lr icho!Janlhill (10 x 10/' CpIO) or 
125 1 _ l r i c 11 0 Ball t 11 i. Il P 1 \I!J \Ill 1 Cl he l1 e <l l r 1 ch 0 san t h .i n ( 60 
}Hj/lnJ) were ac1tlet\ lo the cell!l which were incuhaled at 37° 
C f. 0 r 'I It. l\ ( l. e r UIl b () \Ill <l I 25 I - L r .i c h () fl a Il L hill 11 Cl cl l> e e n 
wanhe(l ouL, lhe cells were incuhated with or without 
unlabelled lricilo!1allthin (GO ,Al(j/ml) al J'7°C aejain. l\t the 
lirne!J iJl(licaled, lriplicale nample!J w(:~re proccs!Jed as 
tlencrihed ulltler "Hal.erialn and Helho(19". 
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. 2 .4. Ui6 u 66ion 
End y tosis is th e u pta k e o f mac r o mo l ec u lar 
mater i a l s i nt o a me mbrane - limi t ed o r g a nelles i n a livi ng 
ce ll. Three d e f ined types of processes ca r r y ou t 
endocytic events (Pastan & Willingham, 1985), wh ich 
includ e phagocytosis (Silverstein et al., 1976), 
pinoc yt o sis (Lewis, 1931; Willingham & Yamada, 1978) and 
receptor-mediated endocytosis. A wide variety of 
molecules have been observed to enter cells by receptor-
mediated endocytosis. During the last two decades it 
has become clear that a number of protein toxins, such 
as diphtheria toxin, ricin and abrin are able to 
penetrate the membrane of cells and get access to 
targets in the cytosol. it now appears that many toxins 
enter vesicles that they reach through receptor-mediated 
endocytosis (Olsnes & Pihl, 1982a). 
As to diphtheria toxin uptake by susceptible cells 
two mechanisms may be operative (Bonventre et al., 
1975). One is a specif ic uptake invol v ing binding of 
diphtheria toxin to specific receptors on the sensitive 
cell surface and receptor-mediated passage of toxin 
through the plasma membrane. The second involves 
internalization of toxin by pinocytosis (Ryser, 1968). 
The latter mechanism is responsible for the entry of the 
I ' , J ) 
III j C . y f o x i n molecules ( Pasta n & Willingham , 1985) . 
O n t h t h r h a nd, the studies on t h e actio n of 
d iph t h ri a toxin by Cuatrecasas and Hollenberg ( 19 7 5) 
sugge s ted t hat resistant cells lack the capac ity to b i nd 
diphtheria toxin at the cell surface and are thus able 
to withstand its toxic effects (Boquet & Pappaenheimer, 
1976; Middlebrook et al., 1978). 
Trichosanthin has shown cytotoxic effects on human 
tumour cells (see Section 2.1). In order to investigate 
the uptake of trichosanthin by susceptible tumour cells 
and elucidate the molecular basis of its cytotoxicity, 
the experiments in this study were designed to determine 
the capacity of both trichosanthin-sensitive human 
choriocarcinoma cells (Jar) and trichosanthin-
insensitive human cervical carcinoma cells (HeLa) to 
bind trichosanthin. 
The results from initial tests show that the 
association of 125 'h th' I-tr1.c osan 1.n with Jar and HeLa 
cells does not appear to fulfill the rigorous 
biophysical criteria of saturability, specificity and 
reversibility of binding proposed by Cuatrecasas et al 
(1975) for identification of receptors. Since these 
initial experiments were performed with cell suspensions 
( (t t ' l"Yf i n ' zati n , a possible sourc o fer r 0 r vJ h i } 
11 n t b x luded i s t hat t he c haracteristics of the 
11 li t ' f (le ma y be c hanged a f t e r the treatment with 
trypsi n \-J h ic h in turn may mask or destroy possible 
r eceptors at cell su r face (Middlebrook et al., 1978). To 
a void thi s c omplication the binding experiments were 
fu rt her c a rr ied out on cell in monolayers. However, the 
pa tt e r n s as seen in Figures 3.2.6 and 3.2.7 were similar 
to tha t obtained from cell suspensions indicating that 
there are nonspecific associations for trichosanthin on 
the surface of both Jar and HeLa cells. 
This study of trichosanthin association kinetics 
s h o \v e d that the binding of 125r-trichosanthin to 
cultured Jar cells increased rapidly for the first 15 
min and reached equilibrium in 30 min. However, no 
unequivocal evidence for reversibility was obtained by 
experiments using excess unlabelled trichosanthin added 
together with the labelled drug. The observation of 
minimal tri c hosanthin dissociation from Jar cells, 
further suggests that its binding to cultured Jar cells 
is irreversible. Since no specific binding of 
trichosanthin with Jar and HeLa cells was demonstrated 
in th i s study, the question of whether or not these 
cell s co n t ain receptors of tr ichosanthin is therefore 
- i ll P ll. 
I t \ .J ass u g g es t e d t hat th e i n t er n a 1 i z a t i o n 0 f 
dipht heria tox i n by pinocytosis is responsible f o r t he 
entry of t he majority of toxin molecules (Pa s tan & 
Willing h am , 1 9 85) The toxins that ente r in t o 
membrane - bo und ves i cles within a cell are usually 
degraded in secondary lysosomes (Olsnes & Pihl, 1982a). 
I f the c e l ls are exposed to toxin in high concentration 
and j or f o r extended periods of time some toxin may 
es c a p e proteolytic digestion and catalyse inactivation 
of a n elongation factor 2 which is required for protein 
s y n thesis in cytoplasm (Olsnes & Pihl, 1982a). As the 
cytotoxic action of tr ichosanthin occurs only after 
su f f ic iently extensive and prolonged exposure to the 
cul t ured c e l ls as described in Section 2.1, a non-
s pecifi c pinocytosis of trichosanthin as a possible 
upt ake mechanism in these tested cell lines can be 
considered. 
To understand the endocytosis of toxic proteins 
many investigators have studied by electron microscopy 
the uptake of toxins linked to horseradish peroxidase, 
ferritin and colloid gold (Olsnes & Sandvig, 1985). 
There f o r e , f u r ther ultrastructural study at subcellular 
1 v 1. \1 d l n 1 1 .l - g 1 1 l abe ll cl tri ' l1 
I , ' / /I , 
a n t h i r a n d 
a n t L- r i . 11 s a n t h i n mo noc l o n a l an i b o dy wil l } e u s f u l t o 
iu idat t h e process of endocytosis of trichosanthin i n 
cultured t umour cells . 
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3.3 Ef fects of Trichosanthin on Macromolecul e 
Synthesis of Choriocarcinoma Cells I n Vitro 
3.3.1 Introduction 
Trichosanthin ia a basic protein with molecular 
weight of 25,600 daltons (Wang et al., 1986). It has 
been reported to have a part of chemical structure 
similar to plant protein toxin ricin A chain (Wang and 
Zhang, 1987). Ricin is a toxic protein synthesis 
inhibitor through enzymatically inactivating the 60S 
ribosomal subunits (Olsnes and Pihl, 1982a,b). The 
inhibitory effect of trichosanthin on protein synthesis 
in cell-free lysate system has been demonstrated (Xiong 
et al., 1980; Yeung et al., 1988). In order to 
investigate the biochemical mechanism of action of 
trichosanthin on tumour cells, its effects on the 
incorporation of tritiated thymidine, uridine and 
methionine were studied in intact cultured human 
choriocarcinoma (Jar) cells in this study. 
11 .1) 
3 . 3 . 2 ~' a t e rials and methods 
Ex p rimenta l Age nts 
Crysta lline trichosanthin (1.2 mg/ml) wa s purchased 
fro m Ji n s h a n Ph a rmaceutical Co. Shanghai, China. It wa s 
d ilu ted wi t h culture med~um prior to addition to cells. 
[met h y l-3 H] thymidine (2.0 Ci/mmol), [5,6- 3H]Uridine (51 
Ci/mmol) and L- [methyl-3 H) methionine (90 Ci/mmol) were 
from Amersham International, PLC, UK. 
Cell culture 
The source and maintenance of human choriocarcinoma 
(Jar) cell line were the same as that previously 
described in Section 2.1. 
DNA, RNA and protein synthesis 
The ef fects of tr ichosanthin on the synthesis of 
DNA, RNA and protein in Jar cells were assessed by the 
amount of tritiated precursors (thymidine, uridine and 
met h ionine, respectively) incorporated into 
ri h l r a tic acid i nsol uble materials derive d f rom 
tr ated cells , a nd compa r e d with unt rea ted controls. 
Logar i t hm ic ally g r owing cells we r e p la te d o u t in 
S triplicate a t 1 x 10 cells per 3S mm diamete r c ul t ure 
dis h ( Cor ning, NY, USA) containing 1 ml of culture 
med i um and i ncubated for 24 h at 37°C. The cells were 
p r e inc u b a ted in the presence of different concentrations 
of t r ichosanthin at 37°C for the time indicated. The 
3 H-la belled precursor was added at a concentration of 1 
J-l Ci/ml and incubation was continued for 1 h at 37°C. 
Hank's balanced salt solution was used in the 
3 h" [ H] met ~on~ne incorporat ion test instead of RPHI1640 
me d ium which contains methionine. At the end of 
incu b a t ion, the cells were washed twice with ice-cold 
phosphate buffered saline (pH 7.4) and once with ice-
cold methanol before cells were extracted with ice-cold 
10% trichloroacetic acid three times. Lastly, the cells 
were digested in 1 M NaOH and the radioactivity was 
counted using 3 ml of scintillation solution containing 
4.S 9 of 1,4-bis[2-(S-phenyloxazolyl) ]benzene 
(POPOP), ISO mg of 2,S-diphenyloxazole (PPO), SOO ml of 
Triton X-lOO per 1 litre of toluene in a liquid 
scintillation counter (Liquid Scintillation Counter LS 
3801, Beckman, USA). The protein content was determined 
u s ing a mo d i fication of Lowry's method as previously 
~ i i n Sec tion 2.1 and the r adiol abel l e d precu rs o r 
incorpo ration is expressed as counts per minu t e per 
milligram of protein. The data is presented a s a 
percentage of the control value. 
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3.3. 3 . Results 
To determine the target site (s) for tr ichosa nt h in 
action, its effects on DNA, RNA and protein synthesis i n 
monolayer cultures of Jar cells was examined. Initially 
a d o se-response relationship was measured by labelling 
for 1 h with radioactive thymidine, uridine or 
methionine after 24 h exposure to various concentration 
of trichosanthin. The inhibition of incorporation of 
[3 H)thymidine and [3 H)methionine was more marked for the 
same concentration of trichosanthin than that of 
3 'd' [ H)url lne, though the three incorporation curves were 
all trichosanthin dose-dependent (Figure 3.3.1). The 50% 
inhibi tory dose of tr ichosanthin for incorporation of 
[3 H )thymidine, 3 'd' [ H)url lne and [3 H)methionine in 
cultured Jar cells after 24 h of incubation was 10.1 ± 
1.7, 37.2 ± 3.1 and 11.1 ± 1.5 ~g/ml respectively. There 
was statistically difference using one way analysis of 
variance (p < 0.01). 
In an effort to see time-dependent inhibition of 
molecular synthesis, changes in the DNA, RNA and protein 
synthesis of Jar cells exposed to 10 ~g/ml trichosanthin 
were observed after pulse labelling for 1 h with 
radioactive precursors at various time points (Figure 
. 2 ). Th inhibition of protein and DNA s yn t hes ' s 
s m d to exceed that of RNA synthesis over th e 
observation period. DNA and protein synthesis '-'Jas 
progressively inhibited with time, and reaching a 
maximum inhibition of 54.8 ± 3.2% and 49.9 ± 2.9% 
respectively after 24 h exposure. However, the rate of 
RNA synthesis slowly decreased with time, 18.9 ± 2.8 % 
inhibition was observed for RNA synthesis even after 
exposure of the cells to trichosanthin for up to 24 h. 
These are statistically different using one way analysis 
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Figure 3.3.1 Effects of varying concentrations of 
trichosanthin on synthesis of DNA, RNA and protein in Jar 
c e 11 s . Cell s vI e to e in cub ate d wit h va r i 0 u s con c e n t rat ion s 0 f 
trichosanthin at 3-' QC in culture medium. After 23 h, [methyl-
JHJthymidine( 0 ), [3 11 ]uridine(.) or [methyl-JH]methionine( fj. ) 
vI a 8 add e d and the cell 8 we rei n c 1I bat e d for a n add i t ion all h 
for pulse labelling of DNA, RNA· Ot- protein, respectively. The 
incorporated radioactivity per milligram of protein was 
measured, and the data represent the average of triplicate, 
plotted as a percentage of the control values (no trichosanthin 
added). Each polnt is the mean ± the SEH of three culture 
di s hes. Repeated experiment was cart" ied out j ndependently, 
a nd similar results vJere obtained in the second experiment of 
ea c h poLnt. 
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Figure 3.3.2 Time course of the inhibitory effect of 
trichosanthin on macromolecule synthesis in cultured Jar cells. 
Cell s vI ere in C II bat e d \oJ i t h 0 II tor wit 11 lOll 9 / In 1 t r i c h 0 san t h in at 
J 7 0 C. 0 N A , n N A 0 r pro t e ins y nth e s is \va s m ea sur e d by add in g 
fmethyl-JIIJthymidine( 0 ), JII)uridine(. or [methyl-
311 ] met h ion i ne ( 6 ), re 8 pe et i vel y , 1 h be f 0 t- e the end 0 f ea c h 
o b set- vat ion per i 0 d . T Il e i n cor po rat e d r a d i 0 act i v i t Y per 
milligram of protein was measured, and the data represent the 
a ve rag e 0 f t rip 1 i cat e , plo t t e cl a sap et- c en t a 9 e 0 f the con t r 0 1 
values (no trichosanlhin added). Each point is the mean ± SEH 
of three dishes. Repeated experiment was carried out 
independently, and siml1ar , reslllts were obtained in the second 
experime nt of ea c h point. 
24 
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3.3.4. Discussion 
Studies of molecular pharmacology (i. e., th e 
interaction of an agent in protein and nucleic acid 
metabolism) can give insight into its mechanism of 
action (Bradner & Claridge, 1984). In this study, the 
effects of trichosanthin on macromolecule synthesis were 
examined in vitro. Jar cells incubated with 
trichosanthin, then pulse-labelled with tritiated 
thymidine, uridine or methionine, showed a more profound 
inhibitory effect on DNA and protein synthesis when 
compared to RNA synthesis. Modulation of cellular 
proliferation and DNA replication subsequent to an 
overall change in the function of the protein synthetic 
machinery has been documented (Brooks, 1977; Lotan et 
al., 1982). Patterns of inhibition of macromolecule 
synthesis often correlate with the cytotoxic mechanism 
of action of the drug (Burres et al., 1989). Immediate 
inhibition of thymidine and uridine incorporation 
suggests binding to nucleic acids, and specific 
inhibition of thymidine incorporation is observed with 
antimetabolites such as cytosine arabinoside. Whereas 
inhibition of thymidine and methionine with intermediate 
effects on uridine incorporation is a pattern produced 
by many inhibitors of protein synthesis such as 
puromycin and cycloheximide, two derivates of the 
111j S genu s of soi l bacter ia ( Burres et al. , 
I 989 ) . I n cor poration experime nts with Jar ce l ls 
i nd i cate d that t r i c hosanthin di s rupted DNA and p r otein 
syn t hesis with less effect on RNA synthesis. Prote i n 
synthes is is also required for cellular RNA synthesis 
Grollman, 1968). Accordingly, inhibition of protein 
synthesis induced by trichosanthin would be expected to 
prevent the synthesis of RNA even to a less extent. 
Therefore, inhibition of protein biosynthesis may be the 
primary mode of action of trichosanthin. The mechanism 
of protein synthesis inhibition induced by trichosanthin 
is not yet clear. Recently Endo et al. (1987) reported 
that ricin A chain is specific N-glycosidase that 
inactivates ribosomes by hydrolysing a single N-
glycosidic bond between an adenine and ribose at a 
specific nucleotide (A-4324) of the 28S rRNA in the 
ribosomes. As trichosanthin has shown some homology to 
ricin A chain (Zhang & Wang, 1987), additional studies 
are necessary to determine if trichosanthin also 
inactivates eukaryotic ribosomes by a similar mechanism 
as ricin A chain. 
I (,' ) 
Chapter 4. General Discussion 
The cytotoxic features of trichosanthin, including 
anti-tumour properties and its possible mechanism of 
action are discussed in this chapter. Additionally the 
future prospects for trichosanthin research are also 
surveyed. 
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4.1. Anti-tumour Activity of Trichosanthin 
The primary aim of this work was to study the anti-
tumour properties of trichosanthin, and to establish 
whether it has any therapeutic potential against human 
tumours. The findings in this work conf irm that 
trichosanthin is a potential anti-tumour agent. 
Early studies demonstrated the ability of 
trichosanthin to inhibit the growth of animal tumour 
cells (Guo et al., 1980; Pan et al., 1985c; Leung et 
al., 1986; Guo et al., 1989). However, the murine 
tumour generally used in the testing of anti-tumour 
agents had a limited predictive value with regard to the 
response of solid human tumours, which grow much more 
slowly (Cline & Haskell, 1980). The anti-tumour effects 
of trichosanthin were therefore tested on human tumour 
lines. The data summarized in Table 2.1.1 and Figures 
2.1.1 and 2.1.2 illustrate the following points: 
(1) although trichosanthin inhibits the growth of 
six human tumour cell lines and two normal 
f ibroblast cell lines in a dose and time 
I / I 
d pe nde n t ma nner , eac h ce l l l i ne x h i b its a 
d if fer ent sensitivity to trichosa n t h i n. 
( 2 ) t he choriocarcinoma cell lines Jar and BeWo 
were the most sensitive, cervical carcinoma 
line CC3 was also very sensitive but ovarian 
clear cell carcinoma aCC1, HeLa and two normal 
fibroblast cell lines (Fib1 and Fib2) were 
quite resistant to the trichosanthin treatment 
in vitro. 
(3) there was no significant correlation between 
IC SO value of trichosanthin and the cell 
population doubling time in eight tested cell 
lines. 
Xiong et al. (1976) reported that trichosanthin 
exerted direct and specific injurious effects on human 
syncytiotrophoblasts, but not on other cell types, such 
as human amniotic cells and hepatoma cells. A later 
study (Xiong & Lu, 1981) showed that trophoblast cells 
of hydatidiform mole were more sensitive to 
trichosanthin when compared to cells of the fetal renal 
cortex, cervical carcinoma HeLa cells, decidual cells, 
1 // 
na p il aryn al carci n o ma cel l s and h e pa t oma c ell s . 
H \vev e r t hese studies were only ba s ed o n morphologi c al 
observatio n i n v it ro, and lacked quan t i ta tive comparison 
o f se n sitiv ity of di f ferent cell lines t owa r d s 
t ri c h osa n t h i n. Recently Tsao et al. (1986) 
quan tit a tive ly tested the sensitivity of eight cell 
lines towards trichosanthin using cell protein content 
assays, and found that choriocarcinoma cell lines (Jar 
a nd BeWo) were sensitive to trichosanthin with an IC 50 
v a lu e of 2.3 and 3.8 pg/ml , while two normal fibroblast 
ce l l lines were insensitive with an IC 50 of more than 10 
~g /m l, respectively. The inhibition of choriocarcinoma 
cel l s by trichosanthin was also dose and time dependent. 
The results in the present study confirmed these 
fin d ings. 
In mainland China tr ichosanthin has been used to 
treat malignant hydatidiform mole and choriocarcinoma 
with success and minimal side effects (Anon., 1972a, 
1975a, 1976f;, Huang, 1987; Jin, 1988; Wang et al., 
1980; Yao, 1978). However, trichosanthin in these 
clinical trials was combined with other Chinese 
medicinal drugs or surgical procedures, and there was no 
strict comparison with a control population, thus 
obscu r ing of t he anti-tumour efficacy of trichosanthin. 
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N v r 11 1 s s t hese i n v itro studies s u pport the cli n i c al 
i mpr s s ion t hat t ri c hosanthin might have potential va l ue 
in t he treatme nt of choriocarcinoma . 
The present study found that the sensitivity o f two 
choriocarcinoma cell lines (Jar and BeWo) to 
trichosanthin treatment are similar, however, 
trichosanthin was cytotoxic against one cervical 
carcinoma cell line (CC3), and less active against 
another (HeLa). The latter finding implies a different 
sensitivity to trichosanthin among cell lines from the 
same tumour type. Thus it serves to emphasize the need 
for evaluating panels of cell lines of the same tumour 
type before making any generalization about tumour-
specific trichosanthin sensitivity (Hill & Whelan, 
1988) . 
Two major problems are associated with chemotherapy 
for human tumours, the toxic side effects of drugs on 
normal cells and the drug resistance (Durrant et al., 
1987). An ideal anti-tumour drug should exhib i t 
selective cytotoxicity (Cline & Haskell, 1980). However 
conventional chemotherapeutic agents often have a very 
nat-r \ oJ l h cap ut ic wi ndow b t wee n ef f i c a c y and norm 1 
i u t x icit y (Le vin, 1 986 ). In v itro st udies of the 
a n t i- t umo u r e f f ect of trichosanthin using a mix ed cell 
c ultu re system in which the normal fibroblast cel l s were 
co - c ul t ured in monolayers with tumour cells supported 
its selective cytotoxicity against malignant cell l i nes, 
as demonstrated in Section 2.1. Any potential tumour 
chemotherapeutic agent must demonstrate preferential 
killing of malignant rather than normal tissue cells 
(Borsa et al., 1986). In fact the use of trichosanthin 
as abortifacient in human beings did not reveal any 
significant side effects on normal tissues and organs, 
especially, not on bone marrow proliferation (Liu et 
al., 1985). Even when tr ichosanthin has been used to 
treat malignant trophoblastic disease, no significant 
intolerable side effects were reported (Jin, 1985; Yao 
et al., 1978). Therefore, selective toxicity of 
trichosanthin against malignant but not normal cells is 
an important factor in its use as a therapeutic agent in 
man. 
The reason for the · selective toxicity of 
trichosanthin is not yet understood. The data 
summarized in Table 2.1.1 illustrates that the cytotoxic 
effects of trichosanthin seem to be independent of the 
11 pr liferation rate , as j u dged b y population 
d ubli ng times . The rap id ly p r ol iferati ng cell lines 
( Fib1 a nd Fib2 ) were quite resistant to t ric hosanthi n. 
Th is i nd i ca t e s that there may be inherent d i ff erences 
be tween cell types, which reflect differences in t he 
cellular pharmacokinetics and mode of action of 
tri c hosanthin (West & Stratford, 1987; Hill & Whelan, 
1988) . Selectivity of action of trichosanthin might be 
due t o difference in cell affinity for trichosanthin, 
t he e fficiency of transportation and internalization of 
the protein into the cell interior or some other 
intrinsic properties in the cell (Leung et al., 1986; 
Tsao et al., 1986). Further studies should be performed 
to evaluate the exact mechanism of selective action and 
the potential role of trichosanthin in the treatment of 
malignancies. 
The combination of two or more cytotoxic anti-
tumour drugs, especially with different site of action 
will have several benefits (Costanzi et al., 1976; Kahn, 
1978): 
(1) if two drugs are synergistic the dose of each 
may be reduced yet with the same overall 
effect. 
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11 or more dr ugs i n a combi nation may re c rui t 
cells i n to t h e c y c l e o r s yn c h ro n ize cells 
alread y in the c ycle, thu s incr e a sing the 
c y to toxicit y of other drugs in the comb i na tion 
wi t hout increasing the systematic toxici t y. 
(3) the emergence of resistant strains of malignant 
cells may be delayed. 
Trich o santhin is a potent protein synthesis 
i nhibitor (see Section 4.2), it appears to have a 
different mechanism of action from conventional 
chemo therapeutic drugs which mainly affect cellular DNA 
(C l ine & Haskell, 1980). Therefore, those tumour cells 
that are resistant or acquire resistance to 
chemotherapeutic drugs will not be cross-resistant to 
toxin-based therapies (FitzGerald et al., 1987). Also, 
natural toxins can kill nondividing cells which some 
conventional therapies do not (FitzGerald & Pastan, 
1 989 ) . As such, trichosanthin may be a distinct 
cytotoxic agent having several attractive features that 
make it useful for combination treatment with other 
conventional chemotherapeutic ·drugs. 
Adriamycin (Guthrie et al., 1978)and cisplatin 
(BOno mi et al., 1985) have been among the most active 
I II 
ru s a g ai n st ma ny hum a n t um o u rs including 
C l l riocarci noma , a nd a re known to act syne rg istically in 
combi nation wi t h other chemotherapeutic drugs (Frei , 
1972 ; Cl i ne & Haskell, 1980). Adriamyc i n or c i spl atin 
were c o mbined with trichosanthin for treatment of 
cultu red Jar and HeLa cells as described in Section 
2 . 3 . An additive effect was observed. The fact that 
t r i chosa nthin has no myelosuppressive toxicity (Liu, 
1 98 5) i n contrast to conventional chemotherapeutic 
age nts. Therefore, the combined use of trichosanthin 
with other anti-tumour drugs may help to reduce the dose 
o f t hese conventional chemotherapeutic agents needed for 
a given patient, hence reducing the known toxic side 
e ff ects and the possibility of the appearance of tumour 
resistance. Nevertheless, further studies on the 
cytotoxicity action of trichosanthin on other normal 
human cells such as hematopoietic, intestinal and 
epidermal cells will be needed to determine the 
effectiveness of combination therapy, in spite of the 
difficulty of cultivation of these normal human cells. 
In vivo assays utilizing the athymic nude mouse 
have been developed for sensitivity testing of 
an ticancer age n t s f or huma n tumours (Winograd et al. , 
J / H 
1 9 7 ) . u 11 m t hods ma y be u sef u l f o r p r cli n ic 1 
x r i ll\ 11 tat i o n a nd f 0 t- pr e d i c t i vet est s 0 f d rug a ct io n 
agai nst a patien t ' s tumo ur (Mat t e rn & Vo lum, 1982 ; 
Giova nella e t al., 1983). Drug a ct ivity ma y be 
determi ned b y quantification of tumou r volume after 
implantatio n subcutaneously (Azar et al., 1984) or in 
the subrenal capsule (Bogden et al., 1982; Giovanella et 
al., 1983), or by prolongation of survival after 
intraperitoneal inoculation (Lockshin et al., 1985). 
An in vivo nude mouse model has been established to 
test the activity of trichosanthin, as described in 
Section 2.4. The human choriocarcinoma Jar cells were 
successfully transplanted into the flank of nude mice. 
Trichosanthin inhibited tumour growth and prolonged the 
life-span when compared to controls. Cells grown as 
tumours in nude mice retain their characteristic 
sensitivity to trichosanthin. The results obtained with 
tr ichosanthin on human chor iocarcinoma xenografts are 
sufficiently encouraging to warrant clinical testing in 
humans. However, how best to accomplish the 
manipulation of dose and duration of exposure is not yet 
clear and will be the subject of future clinical 
investigation. 
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I n n l u si n, t he a n ti-t umo u r pro pe rties o f t he 
pla n t protein tr ichosanthin have bee n te s t e d agai nst 
hum a n tumo urs. In vitro studies show tricho sa n t h in 
s el ec tively inhibits the growth of several human tumour 
ce ll l i nes. Trichosanthin has also proved to be 
effective against tumour in animal model. The 
definit i ve anti-tumour activity in vitro and in vivo and 
its kn o wn minimal side effects render it promising as a 
thera p eutic agent. In addition, the use of 
trichosanthin may be especially interesting when 
combined with conventional anti-tumour drugs which 
usually cause bone marrow suppression and other serious 
toxic side effects. 
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4.2 Mechanism of Action of Trichosanth i n 
Tr ichosanthin is a natural plant product, it has 
s how n i n vitro cytotoxicity and in vivo ant i -tumour 
a c tivity (see Chapter 2). To investigate its mechanism 
of action with a view to further understanding the 
nature of the cytotoxicity of this agent, a series of 
ex periments were undertaken. A human choriocarcinoma 
c e ll line (Jar) that is sensitive to trichosanthin 
treatment was used in these experiments as a prototype 
for the study of the action of this plant protein 
against human tumours in general. 
The investigation of the inhibitory effects of 
trichosanthin on the synthesis of certain macromolecule 
in Jar cells can provide a biochemical basis for the 
known toxic and therapeutic properties of trichosanthin 
(Baserga, 1968). Thus the effects of trichosanthin on 
macromolecule synthesis of cultured intact Jar cells was 
determined. 
The rates of DNA, RNA and protein synthesis were 
assessed by incorporation of their radiolabelled 
precursors thymidine, uridine and methionine, 
J H J 
~ lV ly ( Isra l l et al ., 1987 ). After 24 h e xpos u re 
to 10 j.1g/ ml tric ho s anth i n, t h e v iable Jar cell s 
decreased to 55 % of a con t rol s am p l e . At such 
conce n tr a ti ons of trichosanthin, DNA a n d pr o tein 
sy n thesis were marked ly disrupted in su r viv i ng v i able 
ce lls by a maximum inhibition of 54.8 and 49 . 9 % 
r es p e c tively, while the effects on RNA synthesis were 
less pronounced (see Section 3.3). 
Patterns of inhibition of macromolecule synthesis 
often correlate with the cytotoxic action of the drug 
(Rivest, 1982). Marked inhibition of both DNA and 
protein synthesis, with less effects on RNA synthesis 
are consistent with the effects of known protein 
synthesis inhibitors (Grollman, 1968). Modulation of 
cellular proliferation and DNA replication subsequent to 
an overall change in the function of the protein 
synthetic machinery has been extensively documented 
(Brooks, 1977; Lotan et al., 1982; Stimac et al., 1977). 
Classical inhibitors of protein synthesis in 
eukaryocytes decrease the rate of DNA synthesis with 
little effect on RNA synthesis (Rivest et al., 1982). 
In mammalian cells, cycloheximide does not inhibit total 
RNA synthesis even at concentrations much higher than 
t hat depressing p r otein synthesis, and the RNA effect 
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i s laye d Howe ver , t he pattern of inh i bitio n o f DNA 
sy n t hesis cau sed b y c y c lohe ximide r esemb l es that o f 
protein synt hesis mor e c lo se ly (S isler and Siegel, 
1967 ) . Low co nc e nt r ation s of em i tine p roduce no 
appreciable de pres s i on o f RNA s ynthesis, wherea s pro t e in 
and DNA f ormat i on a re reduced to 10 % an d 2 0% 
respectively of control values (Grollman, 1968 ) . 
Pu r omycin inhibits protein synthesis more than that of 
nucle i c acids, and DNA synthesis appears to be more 
depre s sed than RNA synthesis (Nathan, 1967). 
The selective inhibition of protein synthesis by 
p l ant toxins, abrin and ricin were confirmed by several 
groups o f investigator (Lin et al., 1970; Olsnes & Pihl, 
197 3a, b ) . It was shown that when Ehrlich ascites cells 
were treated with abrin or ricin, the incorporation of 
radio l abelled leucine decreased after an initial lag of 
30 min and stopped after 2 h. The incorporation of 
thymidine was also inhibited by the toxins. However the 
incorpor ation of uridine was only slightly inhibited. 
Therefore the pattern of inhibition of macromolecular 
biosynthesis in intact Jar cells produced by 
trichosanthin qualitatively resembles the above agents. 
Addi t ionally, the inhibition of protein synthesis 
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by "ri h a n t h i n i n a cell-free rabbit reti c uloc y te 
syst III \oJas firs t s hown by Xi o ng et al. (19 80). Th is wa s 
c n f irmed later by other investigators (Wang et al ., 
19 87; Yeung et al . , 1988). Taken together, the finding s 
o n ma c romolecule synthesis in intact Jar tumour cells 
and in cell-free systems suggest that trichosanthin is a 
protein synthesis inhibitor, the effects of 
trichosanthin on protein synthesis may be most closely 
associated with its cytotoxicity. 
The mechanism of inhibition of protein synthesis by 
trichosanthin has not been elucidated. Recently, using 
computer analysis Zhang & Wang (1986) compared the 234 
amino acid residue sequence of trichosanthin (Wang et 
al., 1986) with the 265 residues of ricin A chain (Lamb 
et al., 1985), and found that there exists a remarkable 
sequence homology between them, 91 residues being 
identical and 42 conservative. Kubota et al. (1987) 
further compared the conformation of trichosanthin with 
ricin A chain using a circular dichroism technique. 
They found that the circular dichroism spectra of ricin 
A chain and trichosanthin in aqueous solution at each of 
the three pHs (pH5, 7 and 9) were nearly identical. 
This circular dichroism data indicates a conformational 
similarity between them, even though the two proteins 
are not taxonomically related. These similarities in 
h pri mar y a nd seco n dar y structure b et wee n 
tr i c h san t hin and ricin A chain may lead a s imil a r i t y in 
t hei r mec hanism(s) of cytotoxic action. Ricin, the 
tox ic lect i n from the seeds of castor bean, inhibit s 
prote i n synthesis in eukaryotic ribosomes (for a review, 
see Olsnes & Pihl, 1982b). The protein molecule 
c o nsists of two subunits (the A and B chains) linked by 
a disulfide bond (Olsnes et al., 1974). The A chain 
catalytically inactivates the 60 S subunits of 
susceptible ribosomes probably by blocking the 
elongation phase of protein synthesis (Refsnes et al., 
1974; Olsnes & Pihl, 1982a). The B chain is responsible 
for t he binding of ricin to cell surface and helps the A 
chain to penetrate into the cytoplasm (Olsnes & Pihl, 
1982a) . 
Accumulated evidence (Stirpe et al., 1982; Olsnes & 
Pihl, 1982b) suggests that a panel of natural proteins 
with the ability to inactivate eukaryotic ribosomes are 
widely distributed in plant kingdom. Barbieri & Stirpe 
(1982) proposed to designate those ribosome-inactivating 
proteins existing in nature as single-chain proteins of 
molecule weight around 30,000 daltons and strongly basic 
(PI, isoelectric point often> 9.5) as type 1 and those 
consisting of an A (active) chain of molecule weight 
a r llnd , 0 0 dalton, PI betwee n 4. 8 and 8 with rib som 
i n a ti vati n g protei n p r o pert i es c o v a l e n tl y li nked to a 
B ( bi n di n g ) c ha i n with which binds su gars wit h the 
co n fig u r ation of D-galactose as type 2. 
Ricin, based on its structural and biological 
characteristics, has been listed as a type 2 ribosome-
ina c tivating protein (stirpe & Barbieri, 1986 ) . 
Partial amino acid sequences showed similarities between 
ribosome-inactivating proteins from the same, or from 
different, unrelated plants and even between type 1 
ribosome-inactivating proteins and the A chain of ricin 
or other type 2 ribosome-inactivating proteins (Lappi 
et al., 1985; Houston et al., 1983; Bjorn et al., 1983; 
Ready et al., 1984). 
Trichosanthin is a single chain peptide protein. 
A feature of type 1 ribosome-inactivating proteins is 
their relatively low toxicity to most intact cells as 
compared with toxins of the ricin type, due to the 
absence of B subunit, which consequent poor entry into 
cells (Stirpe & Barbieri, 1986). It has been found that 
trichosanthin has lower toxicity with a IC SO value of 
0.27-4.29 nM (Yeung et al., 1988) compared to 0.0011 nM 
for ricin (Stirpe & Barbieri, 1986). 
Fu rt h rmore , rece n t e x per iments by Xiong e al. , 
( 1989 ) h a v e s hown that solid-ph a se d tric h osanthin 
o v a l e n t ly linked t o a Sepharose column could a ttach 
some compo n e nt of rabbit reticulocyte lysate. Those 
c o mpo nents are surprisingly similar to the ribosomes 
isolated from rabbit reticulocytes. This suggests a 
specific affinity of trichosanthin for ribosomes. 
Therefore a possible site of action of trichosanthin 
would seem to be the ribosomes. This assumes that 
internalized trichosanthin would effectively bind a 
su f f ic ient number of r ibosomes in such manner as to 
cause inhibition of translation on the remaining normal 
mRNA (Olsnes & Pihl, 1980a). At present, it is not 
known whether this is a likely possibility. The exact 
role of the inhibition of translation by trichosanthin 
in its anti-tumour action or even in the concurrent 
inhibition of DNA synthesis and subsequent cell death is 
still unresolved. 
Nevertheless, the above observations together with 
the results presented here supports the hypothesis that 
trichosanthin is a type ·1 of plant single-chain 
ribosome inactivating protein (Yeung et al., 1988). 
Therefore trichosanthin may inhibit protein synthesis of 
sensitive cells through inactivation of ribosome, and 
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11 11 i nh ibit ce ll growt h. Ho we ver t he details of thi s 
pr cess re main unclear, and n e ed t o be further 
i nvest i g a t ed. 
The study of its effect on tumour cell kinetics is 
also important in the understanding of mechanism of drug 
action (Colomb et al., 1989). Typical cycle kinetic 
techniques generally also provide information which can 
be used in creating anti-tumour treatment protocols. In 
a preliminary study to investigate the effect of 
trichosanthin on the cell cycle distribution of Jar 
cells, the DNA contents of randomly growing control 
cells or cells treated with trichosanthin for 24 or 48 h 
were measured by flow cytometry (Wong et al., 1990). 
The results show that treatment with trichosanthin 
caused a concomitant decrease in the proportion of G1-
phase cells and an increase in the the proportion of S-
phase cells in a concentration dependent manner. It has 
been reported that the synthesis of many proteins, such 
as mitosis-related protein, is essential for cells to go 
from the S to M-phase of the cycle (Sisken and Wikes, 
1967). Furthermore trichosanthin has already been shown 
to be a potent inhibitor of protein synthesis (see 
above) . Therefore it is possible that trichosanthin may 
also affect the synthesis of a set of proteins which are 
involved in DNA synthesis and mitosis-related, and hence 
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1 k pr r ssion from t he S to G2+M phase . 1\ s th 
progression fro m G1 to S-phase is not blocked by Lhls 
mechan ism, ce 11 s in it ia lly in G1 when tr ichosan thin vJas 
i n trod u ced into culture continue to enter S phase, thus 
there is a relative decrease in G1-phase cells and 
partial synchronization of the population in the S-phase 
occur. Then a condition of unbalanced growth will 
result. If the extent of unbalanced growth is excessive, 
the cell will die (Cohen & Studziski, 1967). Whether or 
not this mechanism of protein synthesis in part account 
for its effects on cell cycle and cell growth needs 
further study to conclude. 
There are a variety of substances that cross cell 
membranes by means of receptor-mediated endocytosis 
(Pastan & Willingham, 1985). The sensitivities of 
different cell types to protein toxins may be due to a 
lack of toxin receptors in resistant cells (Boquet & 
Pappenheimer, 1976; Middlebrook et al., 1978). However 
radioligand binding studies to characterize the 
interaction between trichosanthin and its receptors in 
cultured cells were unabl~ to demonstrate specific 
trichosanthin binding on either sensitive Jar or 
resistant HeLa cell lines. Recently Xiong et al. were 
also unable to demonstrate the specific binding between 
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h r at" n ma Be Wo cells and 125 I - lab 11 d 
tri hosa n t h i n ( person a l c ommun ic a t i o n, 1989 ). 
I n v ivo l o calization studies fail ed to demo nst r ate 
a speci f ic binding property of trichosanthin wi th 
trophoblast cells (Hsu et al., 1976; Gao and Zhou, 
1978) . It is well known that type 2 ribosome-
inact i va t ing prote ins such as r ic in and abr in, cons ist 
of an effect moiety (A chain) and a carrier moiety (8 
c hain) which binds these toxins to receptors on the cell 
surface (Refsnes et al., 1974, Olsnes & Pihl, 1982a,b). 
Thus a two-step model for the entry of abrin and ricin 
into the cell has been proposed (Refsnes et al., 1974). 
In the first step of this model the toxins bind to 
receptors on the cell surface by the 8 chain, then in 
the second step the toxic A chain penetrates into the 
cytoplasm, where it exerts its action. Endocytotic 
process is involved in the latter step. However unlike 
ricin or abrin, trichosanthin is not a type 2 ribosome-
inactivating protein (Wang et al., 1986). Therefore 
factors other than receptor types may be invol ved in 
the internalization of trichosanthin. 
The regression of malignant tumours that follows 
successful chemotherapy must clearly be accompanied by 
increased cell loss (Searle et al., 1974). The mode of 
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at" 11 d at h fol l owi ng t he e xpos ure to trichosanthin 
~ n vitro was inv e stigated by li g ht a n d electron 
microscopy . Some investigators ha ve drawn at t en tion to 
t he spont a ne ous occurrence in both normal (Kerr, 1971, 
1 973 ; Ker r & Searle, 1973; Wyllie et al., 1973) and 
ne o plastic (Kerr & Searle, 1972) tissues of a 
mo rpho logically distinctive type of cellular death that 
has been called shrinkage necrosis (Kerr, 1971) or 
a po p t 0 si s ( Ke r r eta 1 ., 1972). Apoptosis affects 
s c attered single cells, and is characterized by 
peripheral aggregation of nuclear chromatin and 
c y toplasmic condensation followed by nuclear 
frag mentation and cellular budding to produce membrane-
bound structures with well preserved organelles that are 
called apoptotic bodies. These are usually rapidly 
disposed of by nearby viable cells. 
Searle et al. (1974) reported an electron-
microscope study of the mode of cell death induced by 
four cancer-chemotherapeutic agents, each with a 
different mechanism of chemical action in the Crocker 
mouse sarcoma 180 (stewart et al., 1959) growing as an 
ascites tumour. Deletion of scattered single cells by 
typical apoptosis was observed to take place 
c ontinuously in untreated Crocker tumours. Injection of 
a i n my i n D, mitomyci n C, c y tosine a rabinos i de a nd 
yclo h x i mide mas sively e nh a nced the rate of apo pto s i s 
i n t he t umo u r s. I j ir i and Pot ten (1983) obser ved the 
e nh a nceme n t o f a poptotic changes produced in s p e ci f i c 
r e g i o ns of murine small intestinal mucosa by the 
administration of ten cytotoxic drugs (including 
actinomycin 0 and cycloheximide) and five sources of 
irradiation. More recently Griffiths et al. (1987) 
reported that the toxic plant proteins ricin and abrin 
ind uced apoptotic changes in mammalian lymphoid tissues 
and intestine. 
From the results described in Section 3.1 it can be 
seen that trichosanthin causes in vitro disruption of 
Jar cells with an apoptotic type of cell death. The 
incidence of apoptotic bodies in cultured cells was seen 
to be increased by tr ichosanthin in a time dependent 
manner. However, dead or dying cells were infrequently 
seen in untreated Jar cell culture. Therefore it seems 
that the main mode of trichosanthin induced cell death 
is apoptosis. 
Whilst it would be difficult to ascertain the 
precise mechanism leading to massive Jar cell 
destruction after exposure of trichosanthin. The 
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in - iati n g s i mul i of cell apoptosi s see m t o v ary 
wid ly , a nd the mec hanisms invo l ve d in t he receptio n o f 
t hese s t i muli a r e also heterogeneous (Geh r in g and 
eoff ino, 1977). However the stereotypical changes of 
a po ptosis suggest that a search for underlyin g 
int r acellular events common to many different 
circumstances might be fruitful (Ijiri & Potten. 1983), 
although this search is still at an early stage. 
Unlike cells undergoing necrosis, apoptotic cells 
do not show evidence of increased membrane permeability 
until after the characteristic morphological changes 
have appeared (Wyllie et al., 1981). It was observed 
that the undetached cultured Jar cells after 24 h 
exposure to 4 J.1g/ml trichosanthin were still able to 
exclude trypan blue although 14.6 % of these surviving 
cells had apoptotic changes. In a recent review, Duval 
and Wyllie (1986) suggested that the severity of cell 
membrane damage might determine the mode of cell death, 
so that apoptosis might result from mildly disruptive 
damage, while severe damage causes necrosis. If Jar 
cells intoxicated by trichosanthin die as a result of 
the inhibition of protein synthesis, then one might 
expect perturbations of membrane structure by depletion 
of integral membrane proteins to be a gradual effect. 
This mildly disruptive damage could therefore be 
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xp d c a u s e apop t o s is rat h er t h a n necrosis 
(Griffit h s et al., 1987). Ne ve rtheless , t he na t ure of 
t h e mo lecula r events mediating the cardinal 
mo r phological changes in apoptosis, namely chromatin 
condensation, cytoplasmic contraction, and early 
phagocytosis by resistant tissue cells, remains unclear 
(Wyllie et al., 1981). 
In conclusion, in order to determine the mechanism 
of anti-tumour action of trichosanthin a series of 
studies on the morphological, cellular and molecular 
e vents elicited by trichosanthin in a trichosanthin-
sensitive choriocarcinoma Jar cell line were performed. 
Trichosanthin disrupts protein and DNA synthesis with 
less ef fects on the synthesis of RNA, suggesting it 
inhibits macromolecular synthesis in a manner similar to 
other protein synthesis inhibitors and other ribosome-
inactivating proteins. The morphological changes of 
trichosanthin-treated Jar cells were studied by light 
and electron microscopy. Scattered cells showing 
apoptotic changes could been seen after exposure to 
trichosanthin. The degree of apoptosis also correlated 
well with the duration of exposure to trichosanthin. It 
i s s uggested that apoptosis may be an important form of 
ja r c e ll death caused by trichosanthin. 
Fr o m the data previously reported by oth er 
investigators and presented in this work, one may 
conclude that the anti-tumour activity of trichosanthin 
is most likely a result of inactivation of cellular 
ribosomes leading to inhibition of protein synthesis, 
the perturbation of cell kinetics, the suppression of 
cell growth, intensive cell apoptosis, and ultimately 
cell death. 
4.3 Prospects of Research on Trichosanthin 
How does a new anti-tumour drug get into the 
clinic? Once a substance is found to be effective 
against tumours in laboratory animals and if toxicology 
studies suggest the drug will not be too toxic, Phase I 
studies are proposed (Cline & Haskell, 1980). 
The optimal schedule of trichosanthin with respect 
to tumour cytotoxicity and dose-limiting side-effects 
such as cardiatoxicity, has never been investigated in a 
prospective, randomized manner. As with traditional 
chemotherapy, it will be necessary to establish a 
therapeut ic window, i. e., a dose of tr ichosanthin that 
produces anti-tumour activity without producing 
unacceptable side effects (FitzGerald & Pastan, 1989). 
Clinical trials large enough to study optimal, and 
possibly individualized trichosanthin treatment need to 
be performed. 
While trichosanthin seems to be a cell-killing 
agent, it has strong antigenic determinants (Ke et al., 
1988) which may limit clinical usefulness. The drawback 
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- 11 li n ica l u se of tric h osant h in f o r indu ci n g 
a rti n is t he i nd u ced hypersensitiv it y g e nerated in a 
f e\..; pat i e n t s ( Wa n g et al., 1 989 ) . Every patie nt should 
be tested for hy pe rsensitivi t y against trichosa nt h i n 
prior to administratio n. In an earlier report f r om the 
Rui Ji n Ho s p ital in Shanghai (Anon, 1974b ), one pa t ient 
died of suspected hypersensitivity towards 
trichosanthin. 
Although anaphylaxis is observed only occasionally 
in patients treated with the highly purified 
trichosanthin (Jin, 1985), it is desirable to diminish 
such allergic reactions in order to improve its 
usefulness. One possible solution is to block the 
epitopes that are responsible for this side effect, but 
this require a knowledge of the locations and numbers of 
the epitopes. Studies of its immunological 
characteristics have shown that 16 monoclonal antibodies 
fell into 4 groups, namely TE1, 181, 3A12, and 485 
groups, def ining 4 distinct antigenic determinants or 
determinant areas, respectively (Gu et al., 1986). 
Furthermore, all 5 IgE monoclonal antibodies were 
i ncluded in TE1 group, together with two IgG1 monoclonal 
antibodies. This possibly implies that the determinant 
r ecognized by TE1 g r oup ant i bodies might play a role i n 
I 'JI 
ri hosa n t h i n-specific IgE a n tibod y response in mice (Gu 
tal ., 19 8 6 ). 
The IgE antibody response is frequently induced b y 
a g r oup of antigens, namely allergens (Ekramoddollah, 
1984; Gu et al., 1986). However, the signif icance of 
this result needs further investigation. In order to 
ob t ain information on trichosanthin epitopes their 
binding reactiveness with anti-trichosanthin antibodies 
c ould be utilised to locate the relative sequence 
positions of these epitopes. If this information could 
be obtained, it may be probable to use genetic 
engineering to custom design new toxins for 
chemotherapy. This technology will allow scientists to 
alter the trichosanthin molecule and attempt to remove 
that area causing allergic reactions and nontarget cell 
toxicity, and also to increase the target cell toxicity. 
J i n et al. (1985) reported that the combined use of 
intramuscularly given dexamethasone with 
intraamniotically administered trichosanthin in inducing 
mid-trimester abortion reduced the occurrence of 
allergic reaction. Lu et al. (1988) examined the 
i nfluence of the use dexamethasone on the human immune 
r s p n se to tric h osa n t h i n, a n d found th at s k i n 
rea c tion s , t he ba s ophil degranulation i ndex and IgE 
antibody p r odu c tion could be suppres sed signi f ica ntl y ( p 
< 0.0 5 ). These resu Its suggest tha tit ma y b e 
wor t hwhile to explore combinations with other new immune 
suppressants such as cyclosporine, to diminish poss i b l e 
allergic reactions caused by trichosanthin. 
The availability of monoclonal antibodies (Kohler & 
Milstein, 1975) has stimulated an intensive search for 
antibodies that will recognize specific cells, including 
tumour cells (Akiyama et al., 1985). A number of 
monoclonal antibodies against tumour-associated antigens 
have been described (Capone, et al., 1983; Casellas, et 
al., 1982; Gilliland et al., 1980). One use of such 
antibodies is to link them to various protein toxins 
(immunotoxins) in order to target the toxins to tumour 
cells (Pastan et al., 1986; Vitetta & Urh, 1987). These 
immunotoxins combine the exquisite cell-type selectivity 
of monoclonal antibodies with the potent toxicity of 
toxins. Several groups have demonstrated the potential 
of antibody-toxin conjugates -in eliminating tumour cells 
expressing the corresponding antigen (Pastan et al., 
1986; Vitetta et al., 1987; Frankel, 1988). Antibodies 
have been coupled to a variety of toxin derivatives 
i n l udi n ri i n l\ c hai n, diph t heria tox in l\ chain , and 
ps {I d mon as e xotox i n (Ca r ne var i et al., 1985 ; FitzGerald 
al ., 1983 , 198 6; Gillil a nd et al., 1980; Kronke et 
al ., 19 85 ; Vitetta et al., 1983) In vivo trials of 
immuno t o xins in animal models of tumour therapy ha ve 
sho wn reproducible, therapeutic efficacy (FitzGerald e t 
al., 1986, 1987; Griffin et al., 1987; Kishida et al., 
1983; Willingham et al., 1987). 
Recently, 
preparation of 
Wang et al. (1987) reported the 
a conjugate of trichosanthin to anti-
hepatoma monoclonal antibody which exhibits potentiated 
cytotoxicity to tumour cells in vitro, while free 
trichosanthin had an IC SO approximately SO-fold higher 
than that of the conjugate. Therefore, trichosanthin is 
a promising effector of immunotoxins if its activity 
can be maintained much better after modification of 
cross-l inking reagents. Further work is needed to 
develop new methods for protein conjugation. 
Immunotoxin are relatively large proteins with 
molecular mass often exceeding 17 S, 000 dal tons (Pastan 
et al., 1986). They readily kill cancer cells that are 
growing in tissue culture. However, it is usually more 
diffi c ult t o demonstrate curative anti-tumour effects in 
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n ' mal m dels f ca ncer (Fi t zGeral d & Pasta n, 1989 ). In 
additi n to immunotoxins s mall e r mol ec ula r weight 
co n j uga t e s have been made with other types of ce ll -
b i nd i ng p r oteins. Epidermal growth factor, interleukin 
2, transferrin, and other growth factors have been 
coupled to portions of ricin (Masui et al., 1989) and 
have been shown to kill cells having receptors for these 
facto r s (Raso, 1988). Furthermore, it has recently been 
possible to use gene fusion technique to make these 
conjugates (Pastan & Fitzgerald 1989). Toxins-derived 
gene fusion proteins can be expressed in large 
quantities in Escherichia coli purified from cell 
extracts or the growth medium (Pastan & FitzGerald, 
1989) . 
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Therefore, as a cell-killing agent, to explore 
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the preparation of trichosanthin conjugated with other 
types of cell binding proteins such as epidermal growth 
factor, interleukin 2 and transferrin is also worthwhile 
and may be fruitful. 
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Appendix 1: An Ovarian Clear Cell Carcinoma 
Cell Line OCCl 
A new ovarian tumour cell line, designated aCCl, 
was established and characterized from the ascitic flu id 
of a patient with a clear cell carcinoma of the ovary. 
The cell line grew well without interruption for over 18 
months and over 110 passages. 
Materials and Methods 
A 47-year-old woman had total abdominal 
hysterectomy and bilateral salpingo-oophorectomy for 
ovar ian cyst on 18 January, 1988. Histology of the 
ovarian cyst showed clear cell carcinoma. The tumour is 
composed of papillary or glandular structures consisting 
of sheets of tumour cells with large pleomorphic nuclei 
and clear eosinophilic cytoplasm (Figure 1). After 
operation the patients developed ascites rapidly before 
she received any chemotherapy. A sample of ascitic 
fluid was taken by abdominal paracentesis and subjected 
to primary culture on August 20, 1988. 
Cell Culture Technique 
min. 
The as c itic fluid was centrifuged at 1,000 g for 5 
The sediments were resuspended in the growth 
medium of RPMI 1640 (GIBCO Laboratories, NY, USA) 
supplemented with 10~ fetal bovine serum, 100 IU/ml 
penicillin and 100 pg/ml streptomycin (Flow 
Laboratories, UK). Stationery cell cultures were set up 
in Corning flask (25 cm2 and incubated in 5% CO2 
atmosphere at 37° C. The initial 2 cell colonies 
contained both epithelial tumour cells and fibroblasts. 
The tumour cells were separated from fibroblasts by 
double trypsinization technique with O. 05t trypsin and 
0.02 % EDTA based on the observation that f ibroblasts 
detached earlier from the flask after trypsinization. 
After 4 subcultures, f ibroblasts were found to be 
completely disappeared from the tumour cell population 
in the culture. 
Morphological Observation 
The cultured cells grown on coverslips were fixed 
with 10% formaline and stained with hematoxyline and 
eosin, and the morphology was observed under light 
microscope. Another samples of tumour cells growing on 
collagen matrix in culture dishes were rinsed three 
J'J/ 
i m with phosphate buffered saline ( pH 7.4) and fix e d 
in situ with 2.5% glutaraldehyde in 0.1 M sodium 
cacodylate (pH 7.4) at 4°C. They were then post-fixed 
for 1 h in 1% osmium tetraoxide in the same buffer. For 
transmission electron microscopy, specimens were rinsed 
several times followed by routine procedures for 
dehydration and embedding in Spurr resin. Ultrathin 
sections were stained with uranyl acetate and lead 
citrate and examined with JEOL 100 CX 11 electron 
microscope at 80 kV. for scanning electron microscopy, 
the spec imens were rinsed, dehydrated, cr i tical point 
dried, coated with gold-palladium and examined with a 
JEOL JSM-35CF scanning electron microscope at 15 kV. 
Growth Characteristics 
The growth curve, population doubling time, 
saturation density and plating efficiency were studied 
at the lOth and 40th passage. Cells at concentration of 
5 x 104 cells/ml were seeded into 35 mm diameter 
dishes and incubated at 37°C under humidif ied 5% CO2 
atmosphere. A cell count in three dishes was taken 
daily after trypsinization and the average numbers of 
cells were plotted to obtain the growth curve. The 
population doubling time and saturation density were 
determined by studying the growth curve. Plating 
;)11 
ffi i nc y \oJ as determi ned b y p l ai n t 250 si ngl e suspen d 
c 11 s i n to each of pla s t ic 60 mm di a meter dishe s and 
c u ltu r ing fo r 14 days. the cell colonies f o rmed were 
stai ne d wi t h Giemsa. Plating efficiency was determ i ned 
as t he r a te of t he number of visible colonies (more than 
10 ce lls) to the number of inoculated cells. 
Chromosome Analysis 
Cytogenetic study of OCC1 line was done on passage 
31. Logarithmic phase growing tumour cells, which had 
been maintained in RPMI 1640 Medium with 10% fetal 
bovine serum, was fed with fresh medium 24 h before 
harvest. Colcemid at final concentration of 0.05 ~g per 
milliliter was used for metaphase arrest. Culture was 
trypsinized 5 h after the addition of Colcemid. Cell 
pellet was resuspended in 45 mM KCl at 37° C for 0.5 h. 
After the hypotonic treatment, cells were fixed in 
acetic acid and methanol (vjv=1:3). Metaphase was 
spread by dropping method on dry slides. Chromosomes 
were analyzed after the trypsin Giemsa banding 
technique. 
Heter otransplantation 
) ') f ) 
l\ prox i mate ly 1 .6 x 10 7 ce l ls ( at passage 33) were 
tra n splanted into the f lank of 8 we e k-old f e male nude 
mice (BA LB-Nu/Nu) . The tumours were exam i n ed 
h i s to l ogic ally by light microscopy 5 months after 
tr an sp lan ta tion. 
CA12S Leve l s in Culture Medium 
Approximately 5 x 10 4 cells in triplicate at 
passage 20 were cultured for 2 days and CA125 level in 
the g r owth media was measured by CA125 radioimmunoassay 
(Abbott Lab. USA). 
Results 
Morphological Characteristics of Cell Line 
aCCl cells maintained on glass coverslip grew as 
monolayer of closely opposed epithelial-like cells. The 
individual cells have some variation in size and shape. 
The nuclei, which occupied about 50% of cell profile 
') IIJ 
\v l' irr u lar wit h promi ne n t nu cleoli ( Figure 2 ) . 
Under the tra n s mi ss i o n e l ectron microscope , the tumour 
ce ll s contai ne d a bundant polyribosome s a nd scant y free 
r i bosome s. Isolat ed granular endoplasmic ret icu l um and 
mi t o chondria were also observed. The mitochondr ia 
a p pea r ed rather dense. Most of the tumour cells were 
shown to contain vacuole of different sizes (Figure 3). 
In tumour aggregates, glandular-like structures were 
often seen. Microvilli and tight junctions were also 
present (Figure 4). When tumour cells were growing on 
collagen gel, a basement membrane was always sandwiched 
between tumour cells and collagen matrix (Figure 5). 
Under the scanning electron microscope, the aee1 tumour 
ce l ls growing on collagen formed a continuous sheet. 
Focal area of cell pilling-up was always observed 
( Figure 6). 
Growth Characteristics 
Analysis of the growth curve of the aee1 line 
(Figure 7) shows that at the lOth and 40th passages the 
population doubling times are 38 and 36 h, the plating 
efficiencies are 20% and 22%, the saturation densities 
are 2.22 and 2.25 x 106 cells/35 mm diameter dish, 
r e s pec tive l y. 
') 11 
Ch romosome An alysis 
Fi f t y me taphases were counted. Over ninety percen t 
o f the mitot i c cells at passage 31 showed hypertriploid. 
The i n vitro modal number is around 70-77. 
On the basis of 30 metaphases analyzed, structural 
abnormalities of chromosomes 1,7,8,9,12,16 and 17 were 
found to be consistent in all cells. Descr iptions of 
these abnormalities are listed in Table. 
A typical karyotype of this cell line (F igure 8) 
is: 
74,XX,-1,+t(li 14 ),+t(li 14 ),+del(1),+del(1),+2,+3,+4, 
+5,+5,+5,+6,+7,+7,+t(7i?),+8p+,-9,+del(9),+10,+11,+12, 
+del(12),+13,+15,+16p+,del(17),+19,+20,+21,+marl,+mar2 
Although subcutaneous inoculation with OCCl cells, 
4 out of 4 mice in the series developed a solid tumour 
in the flank, with latent period of 2 to 4 months. 
Tumours were described by light microscopy as clear cell 
c arcinoma. The histology of these tumours resembles 
that of the original tumour from which the OCCl cell 
line wa s der i ved (Figure 9). 
JP 
CA1 25 Le v els i n th e Culture Medium 
When me dium from culture of aCCl cells was analyzed 
for CA125 by radi o immunoassay, the culture medium 
contained 13 U of CA125 per milliliter. Control medium, 
i.e . , medium which had not been exposed to aCC1 cells, 










Figure 1 lIistophotographs of an ovarian clear cell 
carcinoma. The tumour is composed of papillary or 
glandular struclures (a) and sheets of tumour cells (b) 
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Figure 2 Monolayer cultured cells of the DeCl line at 
the 31th passage. Intracytoplasmic vacuoles, nuclei of 
varying sizes, oncI fine granular chromatin with distinct 
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Figure 4 ace! cells growing on collagen gel. A 
basement membrane - like structure (arrow) is found between 
tumour cells and matrix. 






Figure 5 A glandular-like structure with a lumen (L) is 
often seen in tumour aggregates. Note that microvilli 
(arrow) and tight junctions (T) are present. 
)U 
Figure 6 Scanning electron microphotograph ot a sheet ot 
OCCl cells growing on collagen gel. Note that cells are 
accumulating at different spots (A). 
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Fiqure 7 The growth curve o[ the 10th ( 0 ) and 40th ( 
.) cultures. Each point represents the mean value of 
triplicate cullures. The SD did not exceed 10%. 
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Figure 8 Typical karyotype of OCC1 cell line after G-
bandinq In passaae 31. 
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Figure 9 lIistophotograph of sections of a tumour nodule 
ohtained from an athymic nude mOllne. Large nests and 
sheets of carcinoma cells with ahundant vacuolated or 
clear cytoplasm are separated hy delicate fjbrolls septa. 11 
& E, x ~oo. 
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App endix 2 
(A do pL ed fr oll Drrwinko' s MeLh od ) 
ConvenLions 
M : i\ rueaslIrefienL 
HI: lI easlIr crncnL at ~nd of cullure 
H2: IIcasurcfienl al begininig of cullure 
X : nUl1ber of cells 
XI:Cell nUl1ber al end of culLure 
X2: cell nUfiber al begining of culture 
R : ralio XI/X2 
C : ralio of conlrol (Rc) 
A ratio of Isl drug(Ra) 
D ralio of 2nd drug(Rb) 
AB ralio cOllbined (Rab) 
CapiLal and 511311 leLLprs designale safiC group, so, SFa fieans survival 
fraclion of drug A 
Parl I Derivalion of Slalislical Melhod lo Assess the Addilivily of Drugs as 
Proposed by Drewinko el al. (1976). 
For each sample, s1lrvival ralio ( R ) is calculaled as number of cells al lhe 
end of the cullure ( XI ) divided by nUfiber of cells aL begilllng of culture ( X2), 
i.e. R : XI/X2 
Given lhal ex.peril1lenlal raelhod may lhellselves cause a fracLion of cells lo 
die, a conlrol group was inlroduced and used as a comparison for cultures 
containing drugs. 
11 . \ 
T her ' r 0 [ (' , i 1\ (' I I h s L 11 d y , L h (' / (' a [ (' ~ C 111 L u res y s L (' rJ s, L h r (, (; I1 I () I ((: ) , I (; _ 
d r 11 ~ (A ), 211 J d /11 ~ (11), i\ lid co m b i 1\ i\ L ion 0 f J r 11 ~ S (A 11 I. T [ i I' li e it L c Illl lJ( r S '~ ~ r ~ 
ooL /lined, and I.h e foll owin g valu es were obLain ed: 
RaLi o in conLrol ~rOl1p : C 
Ra l io in group wiLh Isl drug: A 
Rati o in gr oup wilh 2nd drug 11 
Ratio in group wilh co ~bined All 
tla fle Sy mool Hean 
ConLrol C i CI, C2, e3 C : Ci /3 
IsL dru g Ai AI,A2,A3 A : Ai /3 
2n d dru g 11 i OI, 02,UJ o : o i /3 
COl1bin ed AB i : AOI,A n2,ABJ AO: All i /3 
Varian ce 
Var( CI ( Ci- C1/2 
Var(A) ( Ai-A)/2 
Var(B) ( ili-B)/2 
VAr(AB)= ( AOi-AA)/2 
Survi val fra cLi ons fr orl A,n, and AB were calculaLe d using correction as 
follows: 
SYrl bol Hean Variance 
Sur vival fr ac Li on SFa SFa A/ C Var(SFa):(A/ C)[Var(A)/(A)tVar( C)/( C) I 
of 1st dr ug 
Sur vival fra cL ion SFb SFb B/C Var(SFb)=(B/C)[Var(n)/( O)+Var(C)/(C)] 
of 2nd drug 
COlloined SFah SFab: AB/C Var(SFab)=(AO/C)[Var(AO)/(A O)tVar( C)/ (C)l 
A sLaLisLical LesL for devialion frorl addilivit.y was conslrucled as foll ows: 
for a given dose of drug A we observe a fracLion of survival cells, SFa;likewise, 
for 0 we obs erve SFo; and for Lhe corobinalion of A and il, we observe SFab. If 
addilivily does lrue, lhen 
SFab = SFIl .SFb 
,and our es limaLe of devialion froll addiLivily lS lhe quantity 
SFab - Sfa.SFb 
T h f' ~ (' ne r 1\ I L he 0 r y 0 f cs l i rn a L i () 11 sa y s l ha L , u n J c r (I ll i le g r I1 1 it I r; 0 I1 d i l i () I1 ~ , 
cs t iru aLf's arc as ympt oL ically lI orre ally Ji sL riuu lrd . ~h ii L I S lI eed ed I S a re eii SUle of 
l hi s de v i i\ L ion 0 n CO li po n en l w i l h i l s va r I an c e , T h IJ S I S , L her c for c , a 11 e c d L 0
es li l1i\ Le va rian ce of lhe quanlily SFab - SFa,SFb 
Var (SFa,SFb) SFa,Var(SFb) SFb,Var(SFa) 
The vari ance of SFab - Sfa,SFb is oblained as Var( SF ab) t Var( SF a, SFb) , and 
our esli fl ale divid ed by Lhe square rool of ils vartanc e IS approxi mal elly normall y 
dislribuLed wiLh !l ean 0 ( under null hypoLhesis of addiliviLy) an d varia nce I, 
The n o r rna li ~e d deviaLi on froll addiliviLy can, lh eref ore, be meas ured as : 
Z : SFab - SFa,S Fb/SQRIVar( SFab) t Var(SFa,SFb)! 
This valu e, 1:, IS dislrib uted nor ma lly, an d its probability can be esli ll ale d 
by consulling th e ~ table, 
If SFab -SFa.SFb is significanlly grealer lhan zero, lh en , survival fraction 
wilh cOflbi ned drugs is grealer lhan lhe addilive effecl of con ponent drugs, and an 
inhib iLory effe cl is dereonslraled, On lhe olher han d, a synergistic effect IS 
demonslraled if lhis value is significanlly less lhan zero, 
To assess overal deviation [rare addilivily wh en se veral different 
concenl ralions of 8 are used, Drewinko corupuled a score for each dose, lhen add 
the score and use the facl lhal lhe SUI1 of n independenl normal deviales is 
distribuled norllaly with lhe variance of an experillenL, we wish la estimate the 
case In which significance IS achieved only because of behaviour at on e dose 
level. Conseqll ently, In su ch cases we eslimale lhe larg esl absolule score and 
relurn lhe abov e pro cedure, Ov eral signifi cance IS nol.ed only if the sec on d retu rn 
l S s i ~nir i r an · l. 
ParL 2 ll('ri y~ Li o ns of SLaLis Lical MeLhod La Ass es s Eff ecL of OrlJ ~ s on Heasu rerl enLs 
frorl Sllrvivin~ Ce lls an AdopLflLion of Lhe MeLhod by Orewiflko 
In Lh e deri va Lion,Lhe slalisLi cs is bas ed ulLiruLly on a survi val fa cLion of 
ce lls, so lhaL ea ch value represenL Lhe facLion 
lI owevp r, ce ll sllrvival may be li casured in oLher param eLers suc h as prolcin 
co nce nLra Lion of survival crlls, ralio acLive suusLraL e incorpora Lio n and so on, 
so Lh aL Lhe mea sur eme nL ( M ) replaces cell nU li ber (X). So, if one pres u ~es that 
Lhe para ffie Ler is a stJrogaLe rleasurerlenL of cell nUrlbers, then, the basic unit of 
fraction rl easurerlenL can be represented as 
No. of cells at end of culture 
R -------------------------------
No. of cells at plaLing 
HeasurerlenL al end of culture 
Measurement aL begining of culture 
Xl HI 
i.e. R : : 
X2 H 2 
and if all cell culLures originaLed frorl the sarle source, lhese rleasure~enls at 
the beginillg of cullure can be assurted to be constant ( K ). 
Therefore, raLio R HI I K 
R : H I K 
Var (R) : (Hi-M)/K (n-I) 
: Yar(lI) / K 
So, if one replaces cell fraction with a measurcrlents 
Ha/K 
SFa =(A/C) (---- ) (Ha/H e) 
He/R 
Var(A) (A/C)(Var(A)/A tVar(C)/C ) 
Ha / K (--------) ! 
Hc / K 
Var(Ha)/K Var(He)/K 
--------- t --------- I 
Ha / K Hc / K 
(Ha/Hc)!Var(Ha)/Ha tVar(Hc)/Hc I 
l.e. lhe formula re~alns essencially un changed, the survival fra ction of a 
l1easllre~enl is aroused on the basis of Lhe conLrolled culLure , assu ra ing Lhe value 
before plaLing ( unmeasured ) lo be consLanL a cross all culLures in Lhe 
experillenls. 
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